PFDN5 (Prefoldin subunit 5) encodes an alpha-type subunit of the heterohexameric prefoldin complex (also known as GimC). The prefoldin complex is a jellyfish-shaped molecular chaperone composed of two alpha subunits (PFDN3, PFDN5) and four beta subunits (PFDN1, PFDN2, PFDN4, PFDN6). Prefoldin functions as a co-chaperone/holdase that captures unfolded nascent polypeptides -- primarily actin and tubulin -- and delivers them to the group II chaperonin TRiC/CCT for ATP-dependent folding. PFDN5 is also known as MM-1 (Myc Modulator-1) and has a well-characterized moonlighting function as a transcriptional corepressor of c-Myc. PFDN5/MM-1 binds the MBII region of the c-Myc N-terminal domain and represses c-Myc transcriptional activity through multiple mechanisms including recruitment of the TIF1beta/HDAC-mSin3 corepressor complex, promotion of c-Myc proteasomal degradation via Rabring7, and negative regulation of Wnt4 expression via Egr-1 binding. The MM-1 isoforms show differential localization: MM-1alpha and MM-1gamma are nuclear and bind c-Myc, while MM-1beta is cytoplasmic and does not repress c-Myc transcription. Beyond cytoskeletal protein folding, the prefoldin complex has been shown to inhibit amyloid-beta fibrillation, suggesting roles in neuroprotection. PFDN5 is also implicated in RNA polymerase assembly through phylogenetic inference from yeast.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005737
cytoplasm
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: GO:0005737 "cytoplasm" is a well-supported cellular component annotation for PFDN5. This IBA annotation was inferred from phylogenetic analysis (PANTHER) with evidence from yeast (SGD:S000001871, SGD:S000004559), Arabidopsis, and human PFDN5 itself. The prefoldin complex is a cytoplasmic chaperone that operates in the cytosol to capture unfolded nascent polypeptides and deliver them to the cytosolic chaperonin TRiC/CCT (PMID:9630229). Liang et al. 2020 (PMID:32699605) describe prefoldin as "a cytoplasmic chaperone protein." The term "cytoplasm" is appropriately broad, as a more specific CC annotation to "prefoldin complex" (GO:0016272) is already present. Having both is correct: one describes the subcellular location and the other describes complex membership.
Reason: PFDN5 operates as part of the cytoplasmic prefoldin complex. The cytoplasm annotation is well-supported and appropriately broad, complementing the more specific prefoldin complex (GO:0016272) annotation. The IBA phylogenetic inference is sound (PMID:9630229, PMID:32699605). Consistent with PFDN1 review.
Supporting Evidence:
PMID:9630229
Prefoldin binds specifically to cytosolic chaperonin (c-cpn) and transfers target proteins to it.
PMID:32699605
As a cytoplasmic chaperone protein, the prefoldin complex is a hybrid oligomer assembled from six different proteins (six subunits).
|
|
GO:1990113
RNA polymerase I assembly
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: GO:1990113 "RNA polymerase I assembly" is an IBA annotation inferred from phylogenetic analysis (PANTHER:PTN000293176) with evidence from yeast (SGD:S000001871). In yeast, prefoldin subunits have been shown to participate in the assembly of RNA polymerases I, II, and III. Tahmaz et al. 2022 describe that "canonical prefoldin contributes to transcription elongation" and has roles in nuclear gene expression control. This function is conserved across eukaryotes per phylogenetic inference and is consistent with the known nuclear localization of PFDN5 isoforms MM-1alpha and MM-1gamma (PMID:32699605). This represents a nuclear, non-core function distinct from the primary cytoplasmic chaperone role.
Reason: RNA polymerase I assembly is a secondary function for PFDN5, distinct from its core cytoplasmic co-chaperone role. The IBA phylogenetic inference from yeast (SGD:S000001871) is reasonable, and prefoldin subunits have documented nuclear roles in transcription-related processes. However, this is not the primary function of PFDN5 in humans.
Supporting Evidence:
PMID:32699605
MM-1β and MM-1δ are mainly localized in the cytoplasm, while MM-1α and MM-1γ are localized in the nucleus, and MM1 isoforms that bind to c-Myc and TIF1β are located in the nucleus [101].
|
|
GO:1990114
RNA polymerase II core complex assembly
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: GO:1990114 "RNA polymerase II core complex assembly" is an IBA annotation inferred from phylogenetic analysis (PANTHER:PTN000293176) with evidence from yeast (SGD:S000001871). In yeast, prefoldin subunits contribute to RNA polymerase II assembly. This function is consistent with the known nuclear localization of PFDN5 isoforms and the broader role of prefoldin in transcription-related processes. However, this is a secondary function for PFDN5 in humans, distinct from its core cytoplasmic chaperone role.
Reason: RNA polymerase II assembly is a secondary function for PFDN5, supported by phylogenetic inference from yeast. While prefoldin subunits have documented roles in nuclear transcription processes, this is not the primary function of PFDN5 in humans, where its core role is as a cytoplasmic co-chaperone.
|
|
GO:1990115
RNA polymerase III assembly
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: GO:1990115 "RNA polymerase III assembly" is an IBA annotation inferred from phylogenetic analysis (PANTHER:PTN000293176) with evidence from yeast (SGD:S000001871). In yeast, prefoldin subunits contribute to RNA polymerase III assembly. This function is consistent with the nuclear roles of prefoldin subunits but represents a secondary function for PFDN5 in humans.
Reason: RNA polymerase III assembly is a secondary function for PFDN5, supported by phylogenetic inference from yeast. Not the core function of PFDN5 in humans.
|
|
GO:0016272
prefoldin complex
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: GO:0016272 "prefoldin complex" is a core cellular component annotation for PFDN5. This IBA annotation was inferred from phylogenetic analysis (PANTHER) with evidence from Drosophila (FB:FBgn0038976), yeast (SGD:S000004559), Arabidopsis, and human PFDN5. PFDN5 is one of the two alpha subunits (PFDN3 and PFDN5) of the heterohexameric prefoldin complex (PMID:9630229, PMID:30955883). The complex is registered in ComplexPortal as CPX-6149 and CPX-25767. Liang et al. 2020 (PMID:32699605) confirm: "Eukaryotic prefoldin complex is a heterohexameric complex like a jellyfish-like structure, consisting of six different subunits (PFDN1-6): two alpha subunits (PFDN3 and PFDN5) and four beta subunits."
Reason: PFDN5 is a core structural alpha subunit of the prefoldin complex. The IBA annotation is phylogenetically well-supported and consistent with extensive experimental evidence from cryo-EM structural studies (PMID:30955883) and reconstitution experiments (PMID:23614719).
Supporting Evidence:
PMID:32699605
Eukaryotic prefoldin complex is a heterohexameric complex like a jellyfish-like structure, consisting of six different subunits (PFDN1–6): two α subunits (PFDN3 and PFDN5) and four β subunits (PFDN1, PFDN2, PFDN4, and PFDN6) [8]
PMID:30955883
Maintaining proteostasis in eukaryotic protein folding involves cooperation of distinct chaperone systems.
|
|
GO:0005634
nucleus
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: GO:0005634 "nucleus" inferred electronically from UniProtKB subcellular location vocabulary mapping. UniProt records isoform-specific localization: isoform 1 (MM-1alpha) and isoform 3 (MM-1gamma) localize to the nucleus, while isoform 2 (MM-1beta) is cytoplasmic. Liang et al. 2020 (PMID:32699605) confirm: "MM-1alpha and MM-1gamma are localized in the nucleus." The nuclear localization is consistent with the moonlighting function of PFDN5/MM-1 as a c-Myc transcriptional corepressor (PMID:9792694). This IEA annotation is correct and consistent with the TAS annotation from PMID:9792694.
Reason: Nuclear localization of PFDN5 is well-established for the MM-1alpha and MM-1gamma isoforms. The IEA mapping from UniProt subcellular location is correct and consistent with the c-Myc corepressor function (PMID:9792694, PMID:32699605).
Supporting Evidence:
PMID:32699605
MM-1β and MM-1δ are mainly localized in the cytoplasm, while MM-1α and MM-1γ are localized in the nucleus, and MM1 isoforms that bind to c-Myc and TIF1β are located in the nucleus [101].
|
|
GO:0005737
cytoplasm
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: GO:0005737 "cytoplasm" inferred electronically from UniProtKB subcellular location vocabulary mapping. UniProt records that isoform 2 (MM-1beta) localizes to the cytoplasm. The prefoldin complex operates primarily in the cytoplasm for its co-chaperone function (PMID:9630229, PMID:32699605). This IEA annotation is consistent with the IBA annotation to the same term and is correct.
Reason: Cytoplasmic localization is correct for PFDN5 -- both for the canonical prefoldin complex function and for the MM-1beta isoform specifically. Consistent with the IBA annotation and experimental evidence.
|
|
GO:0006457
protein folding
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: GO:0006457 "protein folding" inferred electronically from InterPro domain mapping (IPR011599, the prefoldin alpha-type domain). This IEA annotation is consistent with the IDA and NAS annotations to the same term, and with the well-established role of the prefoldin complex in protein folding (PMID:9630229, PMID:30955883).
Reason: The IEA annotation to protein folding via InterPro is correct and consistent with the higher-confidence IDA and NAS annotations. The prefoldin alpha domain (IPR011599) is specifically associated with the protein folding function of the prefoldin complex (PMID:9630229, PMID:30955883).
|
|
GO:0016272
prefoldin complex
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: GO:0016272 "prefoldin complex" inferred electronically from InterPro domain mapping (IPR011599, the prefoldin alpha domain). PFDN5 is one of the two alpha subunits of the heterohexameric prefoldin complex (PMID:9630229, PMID:32699605). This IEA annotation is consistent with the IBA and IDA annotations to the same term.
Reason: PFDN5 is a core structural subunit of the prefoldin complex. The IEA mapping from the prefoldin alpha domain (IPR011599) to prefoldin complex membership is appropriate and consistent with experimental evidence (PMID:9630229, PMID:30955883).
|
|
GO:0032991
protein-containing complex
|
IEA
GO_REF:0000117 |
MARK AS OVER ANNOTATED |
Summary: GO:0032991 "protein-containing complex" was inferred electronically by the ARBA machine learning model (ARBA:ARBA00028902). While technically correct -- PFDN5 is part of the prefoldin complex, which is indeed a protein-containing complex -- this annotation is redundant and overly general given the more specific GO:0016272 "prefoldin complex" annotation that is already present from IBA, IEA, and IDA evidence. The term "protein-containing complex" adds no informational value.
Reason: This is an overly general annotation. PFDN5 is part of the prefoldin complex (GO:0016272), which is a child term of protein-containing complex. The more specific term is already annotated with IBA, IEA, and IDA evidence. The generic "protein-containing complex" adds no useful information. Consistent with PFDN1 review decision.
|
|
GO:0051082
unfolded protein binding
|
IEA
GO_REF:0000002 |
MODIFY |
Summary: GO:0051082 "unfolded protein binding" is being obsoleted (go-ontology#30962). This IEA annotation was inferred electronically from InterPro domain mapping (IPR011599, the prefoldin alpha domain). While prefoldin does indeed bind unfolded proteins, the term "unfolded protein binding" is a pure binding term that fails to capture the functional significance of this interaction. Prefoldin acts as a holdase/transfer chaperone: it captures unfolded substrates (primarily actin and tubulin) and delivers them to the TRiC/CCT chaperonin for folding (PMID:9630229). The more appropriate term is GO:0044183 "protein folding chaperone" which captures the functional chaperone activity rather than just substrate binding. Consistent with PFDN1 review.
Reason: GO:0051082 is being obsoleted. The term describes only a binding activity and does not capture the chaperone function of prefoldin. GO:0044183 "protein folding chaperone" (defined as "Binding to a protein or a protein-containing complex to assist the protein folding process") is the recommended replacement (PMID:9630229, PMID:30955883).
Proposed replacements:
protein folding chaperone
Supporting Evidence:
PMID:9630229
Prefoldin binds specifically to cytosolic chaperonin (c-cpn) and transfers target proteins to it.
PMID:30955883
PFD can act after TRiC bound its substrates to enhance the rate and yield of the folding reaction, suppressing non-productive reaction cycles.
|
|
GO:0005515
protein binding
|
IPI
PMID:17728244 Stimulation of c-Myc transcriptional activity by vIRF-3 of K... |
MARK AS OVER ANNOTATED |
Summary: GO:0005515 "protein binding" (IPI with UniProtKB:Q9DUN1/vIRF-3) from PMID:17728244, a study on Kaposi sarcoma-associated herpesvirus vIRF-3 stimulation of c-Myc transcriptional activity. The UniProt record confirms this interaction (NbExp=8). This is a viral-host interaction where vIRF-3 interacts with PFDN5/MM-1 to modulate c-Myc activity. While the interaction may be biologically relevant in the context of viral infection, "protein binding" is uninformative as an annotation for the host protein PFDN5.
Reason: "Protein binding" is uninformative. While the PFDN5-vIRF-3 interaction is supported by multiple experiments and is relevant to viral manipulation of the c-Myc pathway, the GO term provides no functional insight. The transcriptional corepressor function is better captured by GO:0003714.
|
|
GO:0005515
protein binding
|
IPI
PMID:21516116 Next-generation sequencing to generate interactome datasets. |
MARK AS OVER ANNOTATED |
Summary: GO:0005515 "protein binding" (IPI with UniProtKB:Q13137/CALCOCO2) from PMID:21516116, a next-generation sequencing study to generate interactome datasets. This is a high-throughput interaction study. The biological significance of a PFDN5-CALCOCO2 interaction is unclear. "Protein binding" is uninformative.
Reason: "Protein binding" is uninformative. This high-throughput interaction screen detection does not provide functional insight. The core functions of PFDN5 are already captured by more specific annotations.
|
|
GO:0005515
protein binding
|
IPI
PMID:25036637 A quantitative chaperone interaction network reveals the arc... |
MARK AS OVER ANNOTATED |
Summary: GO:0005515 "protein binding" (IPI with UniProtKB:O14775/GNB5, UniProtKB:P62873/GNB1, UniProtKB:Q9NYS7/WSB2, UniProtKB:Q9UHV9/PFDN2) from PMID:25036637, a quantitative chaperone interaction network study. The PFDN5-PFDN2 interaction is expected since both are subunits of the prefoldin complex (UniProt records NbExp=8 for this interaction). The other interactions are from a large-scale chaperone network study. "Protein binding" is uninformative.
Reason: "Protein binding" is uninformative. The PFDN5-PFDN2 interaction is already captured by prefoldin complex membership (GO:0016272). The other interactions detected in the chaperone network study do not provide functional insight beyond what is captured by GO:0044183 and GO:0016272.
|
|
GO:0005515
protein binding
|
IPI
PMID:25416956 A proteome-scale map of the human interactome network. |
MARK AS OVER ANNOTATED |
Summary: GO:0005515 "protein binding" (IPI with UniProtKB:O76003/GLRX3, UniProtKB:P61289/PSME3, UniProtKB:Q13137/CALCOCO2, UniProtKB:Q9UKT9/IKZF3) from PMID:25416956, a proteome-scale map of the human interactome network. These are high-throughput interactions. The PFDN5-PSME3 interaction (NbExp=6 in UniProt) could reflect a connection between prefoldin and proteasome regulation, consistent with the known role of PFDN5/MM-1 in promoting c-Myc proteasomal degradation. However, "protein binding" remains uninformative.
Reason: "Protein binding" is uninformative. While some interactions (e.g., PSME3) may relate to the proteasome-mediated c-Myc degradation function of PFDN5, the GO term itself provides no functional insight. The core functions are captured by more specific terms.
|
|
GO:0005515
protein binding
|
IPI
PMID:28514442 Architecture of the human interactome defines protein commun... |
MARK AS OVER ANNOTATED |
Summary: GO:0005515 "protein binding" (IPI with UniProtKB:P61758/VBP1, UniProtKB:Q9UHV9/PFDN2) from Huttlin et al. 2017 (PMID:28514442), the BioPlex human interactome study. The PFDN5-PFDN2 interaction (NbExp=8) and PFDN5-VBP1 interaction (NbExp=9) reflect prefoldin complex subunit and prefoldin-like complex interactions. VBP1 (von Hippel-Lindau binding protein 1) is a prefoldin-like protein. These interactions are already captured by GO:0016272. "Protein binding" is uninformative.
Reason: "Protein binding" is uninformative. The PFDN5-PFDN2 and PFDN5-VBP1 interactions reflect co-membership in prefoldin/prefoldin-like complexes, already captured by GO:0016272. The BioPlex study does not add functional insight beyond complex membership.
|
|
GO:0005515
protein binding
|
IPI
PMID:31515488 Extensive disruption of protein interactions by genetic vari... |
MARK AS OVER ANNOTATED |
Summary: GO:0005515 "protein binding" (IPI with UniProtKB:Q9UKT9/IKZF3) from PMID:31515488, a study on extensive disruption of protein interactions by genetic variants. The PFDN5-IKZF3 interaction (NbExp=7 in UniProt) has been detected in multiple studies. IKZF3/Aiolos is a transcription factor, and this interaction could relate to PFDN5's transcriptional regulatory functions. However, "protein binding" is uninformative.
Reason: "Protein binding" is uninformative. While the PFDN5-IKZF3 interaction has been detected multiple times, the GO term provides no functional insight.
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
MARK AS OVER ANNOTATED |
Summary: GO:0005515 "protein binding" (IPI with numerous interactors) from Luck et al. 2020 (PMID:32296183), a reference map of the human binary protein interactome (HuRI). This study detected a very large number of interactions for PFDN5, including with other prefoldin subunits (PFDN2, VBP1), transcription factors, and many other proteins. While the large number of interactions may partly reflect the coiled-coil structure of PFDN5, "protein binding" is uninformative as a GO annotation.
Reason: "Protein binding" is uninformative. This large-scale binary interactome study detected many interactions for PFDN5, but the GO term provides no functional insight. The core molecular functions of PFDN5 are already captured by GO:0044183 (protein folding chaperone) and GO:0003714 (transcription corepressor activity).
|
|
GO:0005515
protein binding
|
IPI
PMID:32814053 Interactome Mapping Provides a Network of Neurodegenerative ... |
MARK AS OVER ANNOTATED |
Summary: GO:0005515 "protein binding" (IPI with UniProtKB:O14901/KLF11, UniProtKB:P42858/HTT, UniProtKB:Q7Z412/PEX26) from PMID:32814053, an interactome mapping study for neurodegenerative disease proteins. The PFDN5-HTT (Huntingtin) interaction is biologically interesting given prefoldin's role in preventing Huntingtin protein aggregation (PMID:32699605). However, "protein binding" remains uninformative.
Reason: "Protein binding" is uninformative. While the PFDN5-HTT interaction may be relevant to prefoldin's neuroprotective role, the GO term provides no functional insight.
|
|
GO:0005515
protein binding
|
IPI
PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling... |
MARK AS OVER ANNOTATED |
Summary: GO:0005515 "protein binding" (IPI with UniProtKB:O14775/GNB5, UniProtKB:P61758/VBP1, UniProtKB:P62873/GNB1, UniProtKB:Q9UHV9/PFDN2) from Huttlin et al. 2021 (PMID:33961781), a dual proteome-scale network study. These are replications of previously observed interactions. The PFDN5-PFDN2 and PFDN5-VBP1 interactions reflect prefoldin complex membership. "Protein binding" is uninformative.
Reason: "Protein binding" is uninformative. These are replications of previously observed interactions that do not add functional insight beyond what is captured by GO:0016272 (prefoldin complex) and GO:0044183 (protein folding chaperone).
|
|
GO:0005515
protein binding
|
IPI
PMID:40205054 Multimodal cell maps as a foundation for structural and func... |
MARK AS OVER ANNOTATED |
Summary: GO:0005515 "protein binding" (IPI with UniProtKB:P62873/GNB1, UniProtKB:Q9NYS7/WSB2, UniProtKB:Q9UHV9/PFDN2) from multimodal cell maps study (PMID:40205054). This is a further replication of known interactions. "Protein binding" is uninformative.
Reason: "Protein binding" is uninformative. These are further replications of known interactions. The relevant functions are already captured by more specific annotations (GO:0044183, GO:0016272).
|
|
GO:0005829
cytosol
|
IDA
GO_REF:0000052 |
ACCEPT |
Summary: GO:0005829 "cytosol" (IDA) from the Human Protein Atlas, based on curation of immunofluorescence data. The prefoldin complex operates in the cytosol for its co-chaperone function, binding nascent polypeptides and delivering them to TRiC/CCT (PMID:9630229). This is consistent with the IBA annotation to "cytoplasm" (GO:0005737) and provides a more specific localization. The cytosolic localization is expected for the canonical chaperone function of PFDN5 as part of the prefoldin complex.
Reason: Cytosol localization is well-supported by immunofluorescence data and is consistent with the cytoplasmic co-chaperone function of the prefoldin complex. This provides a more specific localization than the broader "cytoplasm" annotation.
|
|
GO:0006457
protein folding
|
NAS
PMID:32699605 The functions and mechanisms of prefoldin complex and prefol... |
ACCEPT |
Summary: GO:0006457 "protein folding" (NAS) from ComplexPortal, citing Liang et al. 2020 (PMID:32699605), a comprehensive review of prefoldin complex functions. The review describes how "the prefoldin complex helps protein fold correctly and prevents aggregation by providing class II chaperones ... with a linear, unnatural substrate in the cytoplasm." This NAS annotation is consistent with the IDA annotations to the same term and is well-supported by the review literature.
Reason: Protein folding is the core biological process for PFDN5 as part of the prefoldin complex. This NAS annotation from ComplexPortal cites a well-sourced review (PMID:32699605) that accurately describes the protein folding function.
Supporting Evidence:
PMID:32699605
The prefoldin complex helps protein fold correctly and prevents aggregation by providing class II chaperones (Hsp60 molecular chaperones found in archaebacteria and eukaryotic cytoplasm) with a linear, unnatural substrate in the cytoplasm [2]
|
|
GO:0006457
protein folding
|
NAS
PMID:34761191 A comprehensive analysis of prefoldins and their implication... |
ACCEPT |
Summary: GO:0006457 "protein folding" (NAS) from ComplexPortal, citing Herranz-Montoya et al. 2021 (PMID:34761191), a comprehensive analysis of prefoldins and their implication in cancer. The review describes prefoldins as "evolutionary conserved co-chaperones" that "act as co-chaperones escorting misfolded or non-native proteins to group II chaperonins." This NAS annotation is consistent with the IDA annotations and is well-supported.
Reason: Protein folding is the core biological process for PFDN5. This NAS annotation from ComplexPortal cites a comprehensive review (PMID:34761191) that accurately describes the co-chaperone function of prefoldin subunits.
Supporting Evidence:
PMID:34761191
PFDNs are prevalently organized into hetero-hexameric complexes. Although they have been overlooked since their discovery and their functions remain elusive, several reports indicate they act as co-chaperones escorting misfolded or non-native proteins to group II chaperonins.
|
|
GO:0050821
protein stabilization
|
NAS
PMID:34761191 A comprehensive analysis of prefoldins and their implication... |
KEEP AS NON CORE |
Summary: GO:0050821 "protein stabilization" (NAS) from ComplexPortal, citing Herranz-Montoya et al. 2021 (PMID:34761191). The GO definition of protein stabilization is "Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation." Prefoldin does prevent aggregation of unfolded substrates by capturing them and delivering them to TRiC/CCT (PMID:9630229). However, "protein stabilization" typically implies maintaining a folded protein in its native state, whereas prefoldin acts on unfolded nascent polypeptides as a holdase and transfer chaperone. The term is not entirely wrong but mischaracterizes the nature of the chaperone activity. Consistent with PFDN1 review.
Reason: While prefoldin does prevent protein aggregation (which is part of the GO definition of protein stabilization), the primary function is not to stabilize already-folded proteins but rather to capture unfolded substrates and transfer them to TRiC/CCT for folding. The annotation is not wrong but represents a secondary aspect of prefoldin function. The core process (protein folding, GO:0006457) is already well-annotated with IDA and NAS evidence.
Supporting Evidence:
PMID:34761191
PFDNs are prevalently organized into hetero-hexameric complexes. Although they have been overlooked since their discovery and their functions remain elusive, several reports indicate they act as co-chaperones escorting misfolded or non-native proteins to group II chaperonins.
|
|
GO:0006457
protein folding
|
IDA
PMID:30955883 The Chaperonin TRiC/CCT Associates with Prefoldin through a ... |
ACCEPT |
Summary: GO:0006457 "protein folding" (IDA) from Gestaut et al. 2019 (PMID:30955883), which used cryo-EM, crosslinking mass spectrometry, and biochemical reconstitution to characterize the structural and functional interplay between the prefoldin (PFD) complex and TRiC/CCT chaperonin. The study demonstrates that "PFD can act after TRiC bound its substrates to enhance the rate and yield of the folding reaction, suppressing non-productive reaction cycles." This is the highest-quality direct experimental evidence for the protein folding function of the prefoldin complex.
Reason: This IDA annotation is supported by strong direct experimental evidence from Gestaut et al. 2019 (PMID:30955883), which demonstrated through cryo-EM and biochemical approaches that the PFD-TRiC supra-chaperone assembly enhances protein folding rates. Protein folding is the core biological process for PFDN5.
Supporting Evidence:
PMID:30955883
PFD can act after TRiC bound its substrates to enhance the rate and yield of the folding reaction, suppressing non-productive reaction cycles.
PMID:30955883
The supra-chaperone assembly formed by PFD and TRiC is essential to prevent toxic conformations and ensure effective cellular proteostasis.
|
|
GO:0016272
prefoldin complex
|
IDA
PMID:30955883 The Chaperonin TRiC/CCT Associates with Prefoldin through a ... |
ACCEPT |
Summary: GO:0016272 "prefoldin complex" (IDA) from Gestaut et al. 2019 (PMID:30955883). This study used reconstituted human prefoldin complex (containing all six subunits including PFDN5) and characterized its structure and function through cryo-EM, crosslinking mass spectrometry, and biochemical assays. The cryo-EM structures (PDB: 6NR8, 6NR9, 6NRB, 6NRC, 6NRD) include PFDN5 as chain 5. This provides direct structural evidence for PFDN5 membership in the prefoldin complex.
Reason: PFDN5 is a core structural subunit of the prefoldin complex. This IDA annotation is supported by high-resolution cryo-EM structural data from Gestaut et al. 2019 (PMID:30955883) that directly demonstrates PFDN5 as a component of the human prefoldin complex.
Supporting Evidence:
PMID:30955883
Maintaining proteostasis in eukaryotic protein folding involves cooperation of distinct chaperone systems. To understand how the essential ring-shaped chaperonin TRiC/CCT cooperates with the chaperone prefoldin/GIMc (PFD), we integrate cryoelectron microscopy (cryo-EM), crosslinking-mass-spectrometry and biochemical and cellular approaches to elucidate the structural and functional interplay between TRiC/CCT and PFD.
|
|
GO:0051082
unfolded protein binding
|
IDA
PMID:30955883 The Chaperonin TRiC/CCT Associates with Prefoldin through a ... |
MODIFY |
Summary: GO:0051082 "unfolded protein binding" is being obsoleted (go-ontology#30962). This IDA annotation cites Gestaut et al. 2019 (PMID:30955883), which demonstrated that prefoldin associates with TRiC through a conserved electrostatic interface and undergoes conformational cycling between "latched" (open) and "engaged" (closed) states during substrate transfer. The paper shows that PFD functions not merely as a passive binder of unfolded substrates but as an active co-chaperone. GO:0044183 "protein folding chaperone" is the appropriate replacement. Consistent with PFDN1 review.
Reason: GO:0051082 is being obsoleted. Gestaut et al. 2019 (PMID:30955883) demonstrates that prefoldin functions as a co-chaperone/holdase that cooperates with TRiC/CCT, not merely as an unfolded protein binder. GO:0044183 "protein folding chaperone" accurately describes this co-chaperone activity. The GO:0044183 definition ("Binding to a protein or a protein-containing complex to assist the protein folding process") appropriately encompasses the holdase/transfer function.
Proposed replacements:
protein folding chaperone
Supporting Evidence:
PMID:30955883
PFD can act after TRiC bound its substrates to enhance the rate and yield of the folding reaction, suppressing non-productive reaction cycles.
PMID:30955883
PFD alternates between an open "latched" conformation and a closed "engaged" conformation that aligns the PFD-TRiC substrate binding chambers.
PMID:9630229
Prefoldin binds specifically to cytosolic chaperonin (c-cpn) and transfers target proteins to it.
|
|
GO:0001540
amyloid-beta binding
|
IDA
PMID:23614719 Human prefoldin inhibits amyloid-β (Aβ) fibrillation and con... |
KEEP AS NON CORE |
Summary: GO:0001540 "amyloid-beta binding" (IDA) from Sorgjerd et al. 2013 (PMID:23614719). This study demonstrated that recombinant human prefoldin (hPFD) inhibits amyloid-beta (Abeta 1-42) fibrillation in vitro and induces formation of soluble Abeta oligomers with reduced toxicity. The study used thioflavin T measurements and immunoblotting to show that hPFD directly interacts with Abeta peptides and modifies their aggregation pathway. While this demonstrates that the prefoldin complex can bind Abeta, this is not the core function of PFDN5 -- it reflects the general chaperone/holdase property of prefoldin applied to an amyloidogenic substrate. The annotation was made on the intact prefoldin complex, not PFDN5 individually.
Reason: Amyloid-beta binding is a secondary, non-core function that reflects the general holdase/chaperone activity of the prefoldin complex applied to an amyloidogenic substrate. The study (PMID:23614719) used the intact hexameric complex rather than individual PFDN5. While the data are solid, this represents a peripheral function compared to the core role in actin/tubulin folding via TRiC/CCT delivery. Consistent with PFDN1 review.
Supporting Evidence:
PMID:23614719
we investigated the effect of recombinant human PFD (hPFD) on Abeta(1-42) aggregation in vitro and found that hPFD inhibited Abeta fibrillation and induced formation of soluble Abeta oligomers.
|
|
GO:0016272
prefoldin complex
|
IDA
PMID:23614719 Human prefoldin inhibits amyloid-β (Aβ) fibrillation and con... |
ACCEPT |
Summary: GO:0016272 "prefoldin complex" (IDA) from Sorgjerd et al. 2013 (PMID:23614719). This study expressed and purified recombinant human prefoldin complex (hPFD) to investigate its effect on amyloid-beta aggregation. The successful reconstitution and purification of the hexameric complex containing PFDN5 provides direct evidence for PFDN5 membership in the prefoldin complex. This is consistent with the IDA annotation from PMID:30955883 and the IBA/IEA annotations.
Reason: PFDN5 is a core structural subunit of the prefoldin complex. This IDA annotation from PMID:23614719 provides independent experimental evidence through reconstitution of the human prefoldin hexamer, consistent with the structural data from PMID:30955883.
Supporting Evidence:
PMID:23614719
Prefoldin (PFD) is a molecular chaperone that prevents aggregation of misfolded proteins.
|
|
GO:1905907
negative regulation of amyloid fibril formation
|
IDA
PMID:23614719 Human prefoldin inhibits amyloid-β (Aβ) fibrillation and con... |
KEEP AS NON CORE |
Summary: GO:1905907 "negative regulation of amyloid fibril formation" (IDA) from Sorgjerd et al. 2013 (PMID:23614719). The study demonstrated that recombinant human prefoldin "inhibited Abeta fibrillation and induced formation of soluble Abeta oligomers" that were 30-40% less toxic than Abeta fibrils. Thioflavin T measurements confirmed reduced fibril formation. While the experimental evidence is sound, this represents a non-core function of the prefoldin complex -- an extension of its general holdase/chaperone properties to amyloidogenic substrates. The study was performed on the intact hexameric complex, not PFDN5 individually.
Reason: The experimental evidence from PMID:23614719 is solid, but this is a secondary function reflecting the general anti-aggregation properties of the prefoldin complex rather than its core role in delivering unfolded actin/tubulin to TRiC/CCT. The study was performed in vitro on the intact hexameric complex. Consistent with PFDN1 review.
Supporting Evidence:
PMID:23614719
we investigated the effect of recombinant human PFD (hPFD) on Abeta(1-42) aggregation in vitro and found that hPFD inhibited Abeta fibrillation and induced formation of soluble Abeta oligomers.
PMID:23614719
Our findings show a relation between cytotoxicity of Abeta oligomers and structure and suggest a possible protective role of PFD in AD.
|
|
GO:0045892
negative regulation of DNA-templated transcription
|
IMP
PMID:18281035 Negative regulation of the Wnt signal by MM-1 through inhibi... |
KEEP AS NON CORE |
Summary: GO:0045892 "negative regulation of DNA-templated transcription" (IMP) from PMID:18281035, annotated by BHF-UCL. PFDN5/MM-1 is well-established as a transcriptional corepressor of c-Myc. Mori et al. 1998 (PMID:9792694) originally identified MM-1 as "a novel c-Myc-associating protein that represses transcriptional activity of c-Myc." Liang et al. 2020 (PMID:32699605) describe multiple regulatory mechanisms including inhibition of c-Myc E-box-dependent transcriptional activity via TIF1beta/HDAC-mSin3 recruitment. This is a well-supported moonlighting function of PFDN5 that is independent of its prefoldin complex chaperone role.
Reason: Negative regulation of transcription is a well-supported moonlighting function of PFDN5/MM-1, independent of its core cytoplasmic co-chaperone role. The c-Myc corepressor function is mediated by nuclear isoforms (MM-1alpha, MM-1gamma) and involves recruitment of TIF1beta/HDAC-mSin3 corepressor complex (PMID:9792694, PMID:32699605). Classified as non-core because the primary function of PFDN5 as a prefoldin subunit is protein folding chaperone activity.
Supporting Evidence:
PMID:32699605
(c)MM-1 inhibits the E-box-dependent transcriptional activity of c-Myc by recruiting a histone deacetylase (HDAC-mSin3) complex from TIF1β/KAP1/TRIM28 (a transcriptional co-inhibitor) (Fig
|
|
GO:0090090
negative regulation of canonical Wnt signaling pathway
|
IMP
PMID:18281035 Negative regulation of the Wnt signal by MM-1 through inhibi... |
KEEP AS NON CORE |
Summary: GO:0090090 "negative regulation of canonical Wnt signaling pathway" (IMP) from PMID:18281035, annotated by BHF-UCL. Liang et al. 2020 (PMID:32699605) describe this mechanism: MM-1 negatively regulates the expression of wnt4 by binding to Egr-1, thereby indirectly inhibiting c-Myc expression. This represents one of the multiple mechanisms by which PFDN5/MM-1 inhibits c-Myc activity. This is part of the moonlighting transcriptional regulatory function of PFDN5.
Reason: Negative regulation of Wnt signaling is part of the moonlighting transcriptional regulatory function of PFDN5/MM-1. It represents one of the multiple mechanisms by which MM-1 inhibits c-Myc activity (PMID:32699605). This is a secondary function compared to the core co-chaperone role.
Supporting Evidence:
PMID:32699605
MM-1 negatively regulates the expression of wnt4 by binding to Egr-1, thereby indirectly inhibiting c-Myc expression (Fig
|
|
GO:0005737
cytoplasm
|
TAS
PMID:16130169 Proteomics of human umbilical vein endothelial cells applied... |
ACCEPT |
Summary: GO:0005737 "cytoplasm" (TAS) from PMID:16130169, a proteomics study of human umbilical vein endothelial cells. This study identified PFDN5 in the proteome of HUVECs, consistent with its cytoplasmic localization. The cytoplasmic localization is well-established for the prefoldin complex (PMID:9630229, PMID:32699605) and is consistent with the IBA and IEA annotations to the same term.
Reason: Cytoplasmic localization is well-supported and consistent with the canonical co-chaperone function of the prefoldin complex. This TAS annotation is consistent with multiple other annotations to the same term.
|
|
GO:0003714
transcription corepressor activity
|
TAS
PMID:9792694 MM-1, a novel c-Myc-associating protein that represses trans... |
KEEP AS NON CORE |
Summary: GO:0003714 "transcription corepressor activity" (TAS) from PMID:9792694, the original paper by Mori et al. 1998 that identified MM-1 as "a novel c-Myc-associating protein that represses transcriptional activity of c-Myc." UniProt confirms: "Represses the transcriptional activity of MYC." Liang et al. 2020 (PMID:32699605) describe multiple corepressor mechanisms including recruitment of HDAC-mSin3 complex via TIF1beta/KAP1/TRIM28, proteasomal degradation of c-Myc via Rabring7, and suppression of Wnt4 via Egr-1. This is a well-characterized moonlighting function of PFDN5/MM-1 that is distinct from and independent of its prefoldin complex chaperone role.
Reason: Transcription corepressor activity is a well-established moonlighting function of PFDN5/MM-1, distinct from the core cytoplasmic co-chaperone role. It is mediated specifically by the nuclear isoforms (MM-1alpha, MM-1gamma) and involves binding to the MBII region of c-Myc's N-terminal domain and recruitment of TIF1beta/HDAC-mSin3 corepressor complex (PMID:9792694, PMID:32699605). While this is an important biological function, the primary identity of PFDN5 is as a prefoldin subunit, so this is classified as non-core.
Supporting Evidence:
PMID:32699605
MM-1 is one of the c-Myc NTD-terminated proteins which is bound to the MBII region of the NTD and can compete with TRRAP for c-Myc [99].
PMID:32699605
MM1, a nuclear c-Myc binding protein, inhibits c-Myc activity in the nucleus in various ways and is therefore considered a tumor suppressor.
|
|
GO:0005634
nucleus
|
TAS
PMID:9792694 MM-1, a novel c-Myc-associating protein that represses trans... |
ACCEPT |
Summary: GO:0005634 "nucleus" (TAS) from PMID:9792694, the original paper by Mori et al. 1998 that identified MM-1. The nuclear localization of PFDN5/MM-1 is well-established for the MM-1alpha and MM-1gamma isoforms, which bind c-Myc and function as transcriptional corepressors in the nucleus (PMID:32699605). Consistent with the IEA annotation to the same term from GO_REF:0000044.
Reason: Nuclear localization is well-supported for PFDN5 isoforms MM-1alpha and MM-1gamma. This is consistent with the moonlighting transcriptional corepressor function (PMID:9792694, PMID:32699605) and the IEA annotation.
Supporting Evidence:
PMID:32699605
MM-1β and MM-1δ are mainly localized in the cytoplasm, while MM-1α and MM-1γ are localized in the nucleus, and MM1 isoforms that bind to c-Myc and TIF1β are located in the nucleus [101].
|
|
GO:0006355
regulation of DNA-templated transcription
|
TAS
PMID:9792694 MM-1, a novel c-Myc-associating protein that represses trans... |
KEEP AS NON CORE |
Summary: GO:0006355 "regulation of DNA-templated transcription" (TAS) from PMID:9792694. This is a broad parent term that encompasses the more specific GO:0045892 "negative regulation of DNA-templated transcription" already annotated with IMP evidence from PMID:18281035. PFDN5/MM-1 is well-established as a transcriptional regulator through its c-Myc corepressor function. However, this term is redundant with the more specific GO:0045892 annotation. The annotation should be modified to the more specific child term or kept as-is since GO:0045892 already exists.
Reason: Regulation of transcription is well-supported for PFDN5/MM-1 through its c-Myc corepressor function (PMID:9792694, PMID:32699605). While this term is broader than the existing GO:0045892 annotation, it is not wrong -- PFDN5 does regulate transcription. This is a secondary/moonlighting function. The more specific GO:0045892 from PMID:18281035 provides better resolution.
Supporting Evidence:
PMID:32699605
MM1, a nuclear c-Myc binding protein, inhibits c-Myc activity in the nucleus in various ways and is therefore considered a tumor suppressor.
|
|
GO:0044183
protein folding chaperone
|
IBA
GO_REF:0000033 |
NEW |
Summary: GO:0044183 "protein folding chaperone" is the most appropriate molecular function term for PFDN5 as a prefoldin subunit. This annotation is proposed as a NEW entry to match the IBA annotation that exists for PFDN1 (which has this term with IBA evidence). Prefoldin functions as a holdase/transfer chaperone that captures unfolded nascent polypeptides and delivers them to TRiC/CCT for folding (PMID:9630229). Gestaut et al. 2019 (PMID:30955883) demonstrated that the PFD-TRiC supra-chaperone assembly enhances folding rates. This term is also the recommended replacement for the obsoleting GO:0051082 "unfolded protein binding." Note: PFDN5 does not currently have an explicit IBA annotation to GO:0044183 in the GOA data, unlike PFDN1 which does. The two MODIFY actions for GO:0051082 above recommend this term as replacement.
Reason: GO:0044183 "protein folding chaperone" is the core molecular function of PFDN5 as a prefoldin subunit. PFDN1 already has this annotation with IBA evidence. The prefoldin complex is a bona fide protein folding chaperone that captures unfolded substrates and delivers them to TRiC/CCT (PMID:9630229, PMID:30955883). This term should be added to PFDN5 to replace the obsoleting GO:0051082.
Supporting Evidence:
PMID:9630229
We describe the discovery of a heterohexameric chaperone protein, prefoldin, based on its ability to capture unfolded actin. Prefoldin binds specifically to cytosolic chaperonin (c-cpn) and transfers target proteins to it.
PMID:30955883
PFD can act after TRiC bound its substrates to enhance the rate and yield of the folding reaction, suppressing non-productive reaction cycles.
|
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-02-09T11:18:24.154676'
end_time: '2026-02-09T11:21:34.560573'
duration_seconds: 190.41
template_file: templates/gene_research_go_focused.md
template_variables:
organism: human
gene_id: PFDN5
gene_symbol: PFDN5
uniprot_accession: Q99471
protein_description: 'RecName: Full=Prefoldin subunit 5; AltName: Full=Myc modulator
1; AltName: Full=c-Myc-binding protein Mm-1;'
gene_info: Name=PFDN5; Synonyms=MM1, PFD5;
organism_full: Homo sapiens (Human).
protein_family: Belongs to the prefoldin subunit alpha family.
protein_domains: PFD_alpha_archaea. (IPR011599); Prefoldin. (IPR009053); Prefoldin_subunit_alpha.
(IPR004127); Prefoldin (PF02996)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
temperature: 0.1
citation_count: 18
BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.
DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'PFDN5' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information
Please provide a comprehensive research report on the gene PFDN5 (gene ID: PFDN5, UniProt: Q99471) in human.
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Question: You are an expert researcher providing comprehensive, well-cited information.
Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies
Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.
BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.
DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'PFDN5' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information
Please provide a comprehensive research report on the gene PFDN5 (gene ID: PFDN5, UniProt: Q99471) in human.
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Research report: Human PFDN5 (UniProt Q99471)
Identity verification and nomenclature
- Gene/protein: PFDN5 encodes Prefoldin subunit 5, also known as Myc modulator 1 (MM-1), a canonical α-subunit of the heterohexameric prefoldin complex (α subunits: PFDN3 and PFDN5; β subunits: PFDN1,2,4,6). Verified in human literature describing PFDN5/MM-1 as an α-type subunit and c-Myc-binding protein, consistent with UniProt Q99471 and the prefoldin α family/domains (jellyfish-like architecture with tentacle coiled-coils) (Cell & Bioscience, 2020-07-15, https://doi.org/10.1186/s13578-020-00446-8; Frontiers in Cell & Dev Biol, 2022-01-06, https://doi.org/10.3389/fcell.2021.816214) (liang2020thefunctionsand pages 1-2, tahmaz2022prefoldinfunctionin pages 1-2).
- Organism: Homo sapiens. All cited sources explicitly study human prefoldin/PFDN5 or cross-species conserved functions applied to human PFDN5 (liang2020thefunctionsand pages 1-2, tahmaz2022prefoldinfunctionin pages 1-2).
- Isoforms/subcellular variants: MM-1 isoforms exhibit differential localization (nuclear MM-1α/γ; cytosolic MM-1β/δ), aligning with multifunctional cytoplasmic and nuclear activities (Cell & Bioscience, 2020-07-15, https://doi.org/10.1186/s13578-020-00446-8) (liang2020thefunctionsand pages 8-9).
Key concepts and definitions
- Prefoldin complex: A conserved, ATP-independent co-chaperone that binds nascent/unfolded polypeptides, classically actin/tubulin monomers, and delivers them to the group II chaperonin TRiC/CCT for ATP-dependent folding. The eukaryotic complex is a heterohexamer with a jellyfish-like double β-barrel core and six tentacle-like coiled coils that capture substrates (Cell & Bioscience, 2020-07-15, https://doi.org/10.1186/s13578-020-00446-8; Frontiers in Cell & Dev Biol, 2022-01-06, https://doi.org/10.3389/fcell.2021.816214) (liang2020thefunctionsand pages 1-2, tahmaz2022prefoldinfunctionin pages 1-2).
- PFDN5/MM-1: The α-subunit that, in addition to canonical cytosolic chaperone roles, binds c-Myc and modulates its transcriptional activity, linking prefoldin biology to transcriptional regulation and oncogenic signaling (Adv Exp Med Biol, 2018-01-01, https://doi.org/10.1007/978-3-030-00737-9_1; Cell & Bioscience, 2020-07-15) (payanbravo2018functionalcontributionsof pages 1-3, liang2020thefunctionsand pages 6-8).
Primary functions and mechanistic roles
- Cytosolic co-chaperone: Prefoldin binds nascent actin and tubulin, prevents aggregation, and transfers clients to TRiC/CCT, accelerating folding efficiency (reported up to ~5-fold in yeast systems), which is mechanistically conserved and underpins cytoskeletal assembly (Cell & Bioscience, 2020-07-15; Frontiers in Cell & Dev Biol, 2022-01-06) (liang2020thefunctionsand pages 1-2, tahmaz2022prefoldinfunctionin pages 3-5, tahmaz2022prefoldinfunctionin pages 1-2).
- Transcriptional regulation via c-Myc: PFDN5/MM-1 directly binds c-Myc, acting as a corepressor and facilitating suppression of c-Myc–dependent transcription; PFDN5 has also been linked to proteasome-mediated degradation pathways impacting c-Myc abundance, integrating chaperone, transcriptional, and proteostasis mechanisms (Adv Exp Med Biol, 2018-01-01, https://doi.org/10.1007/978-3-030-00737-9_1; Cell & Bioscience, 2020-07-15) (payanbravo2018functionalcontributionsof pages 1-3, liang2020thefunctionsand pages 6-8).
- Nuclear gene-expression control and RNA processing: Canonical prefoldin contributes to transcription elongation and co-transcriptional pre-mRNA splicing. Loss of prefoldin decreases RNAPII Ser2 phosphorylation and impairs splicing factor recruitment (e.g., U2AF65), linking prefoldin to chromatin-associated gene expression control; these findings provide a framework for PFDN5’s nuclear roles (Frontiers in Cell & Dev Biol, 2022-01-06, https://doi.org/10.3389/fcell.2021.816214) (tahmaz2022prefoldinfunctionin pages 3-5).
Subcellular localization
- Cytoplasm: Canonical localization for co-chaperone roles capturing nascent cytoskeletal clients and transferring to TRiC/CCT (tahmaz2022prefoldinfunctionin pages 1-2).
- Nucleus: Multiple prefoldin subunits, including PFDN5/MM-1, localize to the nucleus where they participate in transcriptional regulation and nuclear proteostasis; MM-1α/γ isoforms are predominantly nuclear, consistent with c-Myc modulation and gene-expression functions (Cell & Bioscience, 2020-07-15; Frontiers in Cell & Dev Biol, 2022-01-06) (liang2020thefunctionsand pages 8-9, tahmaz2022prefoldinfunctionin pages 3-5).
Pathways and molecular interactions
- Chaperone network: PFDN5 functions within the canonical prefoldin complex upstream of TRiC/CCT, integrating with proteostasis pathways that manage cytoskeletal clients and misfolded proteins (liang2020thefunctionsand pages 1-2, tahmaz2022prefoldinfunctionin pages 1-2).
- Transcription/chromatin axis: Prefoldin influences transcription elongation (RNAPII Ser2 phosphorylation) and co-transcriptional splicing, and PFDN5 engages c-Myc-dependent transcriptional programs as a modulator/corepressor (tahmaz2022prefoldinfunctionin pages 3-5, payanbravo2018functionalcontributionsof pages 1-3).
- Proteasome-mediated regulation: Prefoldin complexes and subunits can facilitate ubiquitin–proteasome processing of nuclear proteins; PFDN5 has been implicated in pathways leading to reduced c-Myc activity and stability, aligning with tumor-suppressive functions in specific contexts (payanbravo2018functionalcontributionsof pages 1-3, liang2020thefunctionsand pages 6-8).
Recent developments and latest research (priority 2023–2024)
- Epigenetic suppression of PFDN5 in colorectal cancer (CRC): KDM5C demethylates H3K4me3 at the PFDN5 promoter, repressing PFDN5 transcription and thereby enhancing c-Myc signaling and CRC progression. In a 72-patient cohort, high KDM5C correlated with poor survival and low PFDN5 with improved outcomes. Knockdown of KDM5C reduced malignant phenotypes; simultaneous PFDN5 knockdown rescued these effects, defining a KDM5C→PFDN5→c-Myc axis (Molecular Medicine, 2024-01-03, https://doi.org/10.1186/s10020-023-00775-7) (yu2024lysinedemethylase5c pages 1-2).
Current applications and real-world implementations
- Biomarker potential: Reviews and integrative analyses propose PFDN5/MM-1 as a tumor-associated marker with context-dependent expression (down in hematologic and some epithelial cancers; up in others), and downregulation in blood of Alzheimer’s patients has been reported. Although translational assays are not standardized, these observations support exploration of PFDN5 as a prognostic/diagnostic biomarker in oncology and neurodegeneration (Frontiers in Cell & Dev Biol, 2022-01-06, https://doi.org/10.3389/fcell.2021.816214; Cell & Bioscience, 2020-07-15) (tahmaz2022prefoldinfunctionin pages 8-9, liang2020thefunctionsand pages 6-8).
- Therapeutic concepts: The 2024 CRC study highlights an actionable epigenetic axis in which pharmacologic modulation of KDM5C or restoration of PFDN5 might attenuate c-Myc oncogenic signaling; this provides a rationale for drug discovery targeting PFDN5 transcriptional control in c-Myc–driven tumors (Molecular Medicine, 2024-01-03) (yu2024lysinedemethylase5c pages 1-2).
Expert opinions and analysis from authoritative sources
- Syntheses in peer-reviewed reviews emphasize that prefoldin’s canonical cytosolic role is well-established, but growing evidence supports nuclear functions in transcription and RNA processing. These reviews consistently identify PFDN5/MM-1 as the key link to c-Myc regulation and as a representative example of subunit-specific functions, underscoring PFDN5’s dual cytosolic/nuclear roles and disease relevance (Frontiers in Cell & Dev Biol, 2022-01-06; Adv Exp Med Biol, 2018-01-01; Cell & Bioscience, 2020-07-15) (tahmaz2022prefoldinfunctionin pages 1-2, payanbravo2018functionalcontributionsof pages 1-3, liang2020thefunctionsand pages 1-2).
Relevant statistics and data from recent studies
- CRC cohort size and associations: In Yu et al. (2024), n=72 patient samples were used to associate high KDM5C with poor survival and low PFDN5 with better outcomes; functional rescue experiments (KDM5C knockdown phenotypes reversed by PFDN5 knockdown) quantitatively support the regulatory axis (Molecular Medicine, 2024-01-03) (yu2024lysinedemethylase5c pages 1-2).
- Folding efficiency: Prefoldin can enhance CCT-mediated folding efficiency of cytoskeletal clients by up to ~5× in yeast experiments, reflecting the mechanistic significance of the prefoldin→TRiC handoff (Cell & Bioscience, 2020-07-15) (liang2020thefunctionsand pages 1-2).
- Expression trends across diseases: Compiled evidence indicates PFDN5 downregulation in specific leukemias/lymphomas and in whole-blood samples from Alzheimer’s disease patients, with upregulation reported in non-small cell lung cancer—emphasizing tissue- and disease-specific regulation (Frontiers in Cell & Dev Biol, 2022-01-06) (tahmaz2022prefoldinfunctionin pages 8-9).
Biological role synthesis
PFDN5/MM-1 is a canonical α-subunit of the prefoldin co-chaperone that contributes to cytoskeletal proteostasis by capturing nascent actin/tubulin and accelerating their productive folding via TRiC/CCT. In the nucleus, PFDN5/MM-1 acts as a c-Myc-binding protein that represses c-Myc–dependent transcription and is embedded in broader prefoldin functions that support transcription elongation and co-transcriptional splicing through effects on RNAPII Ser2 phosphorylation and splicing factor recruitment. Disease studies, particularly in 2024 CRC research, position PFDN5 as a functional brake on c-Myc signaling whose expression is epigenetically suppressed by KDM5C. Together, these findings assign PFDN5 a dual role at the interface of proteostasis and gene regulation with translational potential in oncology and neurodegeneration (liang2020thefunctionsand pages 1-2, tahmaz2022prefoldinfunctionin pages 3-5, payanbravo2018functionalcontributionsof pages 1-3, yu2024lysinedemethylase5c pages 1-2, tahmaz2022prefoldinfunctionin pages 8-9).
Gaps and future directions
- Precise structural determinants mediating PFDN5–c-Myc interaction and their modulation by post-translational modifications warrant high-resolution studies.
- The extent to which PFDN5 acts independently versus as part of the holo-prefoldin complex in nuclear functions remains to be fully resolved in human systems.
- Clinical validation is needed to establish PFDN5 as a robust biomarker and to assess therapeutic strategies targeting the KDM5C–PFDN5–c-Myc axis.
References (URLs and publication dates)
- Liang et al., Cell & Bioscience, 2020-07-15. The functions and mechanisms of prefoldin complex and prefoldin-subunits. https://doi.org/10.1186/s13578-020-00446-8 (liang2020thefunctionsand pages 1-2, liang2020thefunctionsand pages 6-8, liang2020thefunctionsand pages 8-9)
- Yu et al., Molecular Medicine, 2024-01-03. KDM5C inhibits transcription of PFDN5 to activate c-Myc signaling in CRC. https://doi.org/10.1186/s10020-023-00775-7 (yu2024lysinedemethylase5c pages 1-2)
- Tahmaz et al., Frontiers in Cell & Developmental Biology, 2022-01-06. Prefoldin function in cellular protein homeostasis and human diseases. https://doi.org/10.3389/fcell.2021.816214 (tahmaz2022prefoldinfunctionin pages 1-2, tahmaz2022prefoldinfunctionin pages 3-5, tahmaz2022prefoldinfunctionin pages 8-9)
- Payán-Bravo et al., Advances in Experimental Medicine and Biology, 2018-01-01. Functional Contributions of Prefoldin to Gene Expression. https://doi.org/10.1007/978-3-030-00737-9_1 (payanbravo2018functionalcontributionsof pages 1-3)
References
(liang2020thefunctionsand pages 1-2): Jiaxin Liang, Longzheng Xia, Linda Oyang, Jinguan Lin, Shiming Tan, Pin Yi, Yaqian Han, Xia Luo, Hui Wang, Lu Tang, Qing Pan, Yutong Tian, Shan Rao, Min Su, Yingrui Shi, Deliang Cao, Yujuan Zhou, and Qianjin Liao. The functions and mechanisms of prefoldin complex and prefoldin-subunits. Cell & Bioscience, Jul 2020. URL: https://doi.org/10.1186/s13578-020-00446-8, doi:10.1186/s13578-020-00446-8. This article has 70 citations and is from a peer-reviewed journal.
(tahmaz2022prefoldinfunctionin pages 1-2): Ismail Tahmaz, Somayeh Shahmoradi Ghahe, and Ulrike Topf. Prefoldin function in cellular protein homeostasis and human diseases. Frontiers in Cell and Developmental Biology, Jan 2022. URL: https://doi.org/10.3389/fcell.2021.816214, doi:10.3389/fcell.2021.816214. This article has 48 citations and is from a poor quality or predatory journal.
(liang2020thefunctionsand pages 8-9): Jiaxin Liang, Longzheng Xia, Linda Oyang, Jinguan Lin, Shiming Tan, Pin Yi, Yaqian Han, Xia Luo, Hui Wang, Lu Tang, Qing Pan, Yutong Tian, Shan Rao, Min Su, Yingrui Shi, Deliang Cao, Yujuan Zhou, and Qianjin Liao. The functions and mechanisms of prefoldin complex and prefoldin-subunits. Cell & Bioscience, Jul 2020. URL: https://doi.org/10.1186/s13578-020-00446-8, doi:10.1186/s13578-020-00446-8. This article has 70 citations and is from a peer-reviewed journal.
(payanbravo2018functionalcontributionsof pages 1-3): Laura Payán-Bravo, Xenia Peñate, and Sebastián Chávez. Functional contributions of prefoldin to gene expression. Advances in experimental medicine and biology, 1106:1-10, Jan 2018. URL: https://doi.org/10.1007/978-3-030-00737-9_1, doi:10.1007/978-3-030-00737-9_1. This article has 20 citations and is from a peer-reviewed journal.
(liang2020thefunctionsand pages 6-8): Jiaxin Liang, Longzheng Xia, Linda Oyang, Jinguan Lin, Shiming Tan, Pin Yi, Yaqian Han, Xia Luo, Hui Wang, Lu Tang, Qing Pan, Yutong Tian, Shan Rao, Min Su, Yingrui Shi, Deliang Cao, Yujuan Zhou, and Qianjin Liao. The functions and mechanisms of prefoldin complex and prefoldin-subunits. Cell & Bioscience, Jul 2020. URL: https://doi.org/10.1186/s13578-020-00446-8, doi:10.1186/s13578-020-00446-8. This article has 70 citations and is from a peer-reviewed journal.
(tahmaz2022prefoldinfunctionin pages 3-5): Ismail Tahmaz, Somayeh Shahmoradi Ghahe, and Ulrike Topf. Prefoldin function in cellular protein homeostasis and human diseases. Frontiers in Cell and Developmental Biology, Jan 2022. URL: https://doi.org/10.3389/fcell.2021.816214, doi:10.3389/fcell.2021.816214. This article has 48 citations and is from a poor quality or predatory journal.
(yu2024lysinedemethylase5c pages 1-2): Fulong Yu, Liang Li, Yimei Gu, Songquan Wang, Lianbang Zhou, Xiaohu Cheng, Heng Jiang, Yang Huang, Yingfeng Zhang, Wenbao Qian, Xianghua Li, and Zhining Liu. Lysine demethylase 5c inhibits transcription of prefoldin subunit 5 to activate c-myc signal transduction and colorectal cancer progression. Molecular Medicine, Jan 2024. URL: https://doi.org/10.1186/s10020-023-00775-7, doi:10.1186/s10020-023-00775-7. This article has 6 citations and is from a peer-reviewed journal.
(tahmaz2022prefoldinfunctionin pages 8-9): Ismail Tahmaz, Somayeh Shahmoradi Ghahe, and Ulrike Topf. Prefoldin function in cellular protein homeostasis and human diseases. Frontiers in Cell and Developmental Biology, Jan 2022. URL: https://doi.org/10.3389/fcell.2021.816214, doi:10.3389/fcell.2021.816214. This article has 48 citations and is from a poor quality or predatory journal.
id: Q99471
gene_symbol: PFDN5
product_type: PROTEIN
status: IN_PROGRESS
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
PFDN5 (Prefoldin subunit 5) encodes an alpha-type subunit of the heterohexameric
prefoldin complex (also known as GimC). The prefoldin complex is a jellyfish-shaped
molecular chaperone composed of two alpha subunits (PFDN3, PFDN5) and four beta
subunits (PFDN1, PFDN2, PFDN4, PFDN6). Prefoldin functions as a co-chaperone/holdase
that captures unfolded nascent polypeptides -- primarily actin and tubulin -- and
delivers them to the group II chaperonin TRiC/CCT for ATP-dependent folding. PFDN5
is also known as MM-1 (Myc Modulator-1) and has a well-characterized moonlighting
function as a transcriptional corepressor of c-Myc. PFDN5/MM-1 binds the MBII region
of the c-Myc N-terminal domain and represses c-Myc transcriptional activity through
multiple mechanisms including recruitment of the TIF1beta/HDAC-mSin3 corepressor complex,
promotion of c-Myc proteasomal degradation via Rabring7, and negative regulation of Wnt4
expression via Egr-1 binding. The MM-1 isoforms show differential localization: MM-1alpha
and MM-1gamma are nuclear and bind c-Myc, while MM-1beta is cytoplasmic and does not
repress c-Myc transcription. Beyond cytoskeletal protein folding, the prefoldin complex
has been shown to inhibit amyloid-beta fibrillation, suggesting roles in neuroprotection.
PFDN5 is also implicated in RNA polymerase assembly through phylogenetic inference from yeast.
alternative_products:
- name: 1 (MM1-alpha)
id: Q99471-1
- name: 2 (MM1-beta)
id: Q99471-2
sequence_note: VSP_043104
- name: 3 (MM1-gamma)
id: Q99471-3
sequence_note: VSP_043103
existing_annotations:
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
GO:0005737 "cytoplasm" is a well-supported cellular component annotation for
PFDN5. This IBA annotation was inferred from phylogenetic analysis (PANTHER)
with evidence from yeast (SGD:S000001871, SGD:S000004559), Arabidopsis, and
human PFDN5 itself. The prefoldin complex is a cytoplasmic chaperone that
operates in the cytosol to capture unfolded nascent polypeptides and deliver
them to the cytosolic chaperonin TRiC/CCT (PMID:9630229). Liang et al. 2020
(PMID:32699605) describe prefoldin as "a cytoplasmic chaperone protein." The
term "cytoplasm" is appropriately broad, as a more specific CC annotation to
"prefoldin complex" (GO:0016272) is already present. Having both is correct:
one describes the subcellular location and the other describes complex membership.
action: ACCEPT
reason: >-
PFDN5 operates as part of the cytoplasmic prefoldin complex. The cytoplasm
annotation is well-supported and appropriately broad, complementing the more
specific prefoldin complex (GO:0016272) annotation. The IBA phylogenetic
inference is sound (PMID:9630229, PMID:32699605). Consistent with PFDN1 review.
supported_by:
- reference_id: PMID:9630229
supporting_text: >-
Prefoldin binds specifically to cytosolic chaperonin (c-cpn) and transfers
target proteins to it.
- reference_id: PMID:32699605
supporting_text: >-
As a cytoplasmic chaperone protein, the prefoldin complex is a hybrid
oligomer assembled from six different proteins (six subunits).
- term:
id: GO:1990113
label: RNA polymerase I assembly
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
GO:1990113 "RNA polymerase I assembly" is an IBA annotation inferred from
phylogenetic analysis (PANTHER:PTN000293176) with evidence from yeast
(SGD:S000001871). In yeast, prefoldin subunits have been shown to participate
in the assembly of RNA polymerases I, II, and III. Tahmaz et al. 2022 describe
that "canonical prefoldin contributes to transcription elongation" and has
roles in nuclear gene expression control. This function is conserved across
eukaryotes per phylogenetic inference and is consistent with the known nuclear
localization of PFDN5 isoforms MM-1alpha and MM-1gamma (PMID:32699605). This
represents a nuclear, non-core function distinct from the primary cytoplasmic
chaperone role.
action: KEEP_AS_NON_CORE
reason: >-
RNA polymerase I assembly is a secondary function for PFDN5, distinct from
its core cytoplasmic co-chaperone role. The IBA phylogenetic inference from
yeast (SGD:S000001871) is reasonable, and prefoldin subunits have documented
nuclear roles in transcription-related processes. However, this is not the
primary function of PFDN5 in humans.
supported_by:
- reference_id: PMID:32699605
supporting_text: >-
MM-1β and MM-1δ are mainly localized in the cytoplasm, while MM-1α and
MM-1γ are localized in the nucleus, and MM1 isoforms that bind to c-Myc
and TIF1β are located in the nucleus [101].
- term:
id: GO:1990114
label: RNA polymerase II core complex assembly
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
GO:1990114 "RNA polymerase II core complex assembly" is an IBA annotation
inferred from phylogenetic analysis (PANTHER:PTN000293176) with evidence from
yeast (SGD:S000001871). In yeast, prefoldin subunits contribute to RNA
polymerase II assembly. This function is consistent with the known nuclear
localization of PFDN5 isoforms and the broader role of prefoldin in
transcription-related processes. However, this is a secondary function for
PFDN5 in humans, distinct from its core cytoplasmic chaperone role.
action: KEEP_AS_NON_CORE
reason: >-
RNA polymerase II assembly is a secondary function for PFDN5, supported by
phylogenetic inference from yeast. While prefoldin subunits have documented
roles in nuclear transcription processes, this is not the primary function
of PFDN5 in humans, where its core role is as a cytoplasmic co-chaperone.
- term:
id: GO:1990115
label: RNA polymerase III assembly
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
GO:1990115 "RNA polymerase III assembly" is an IBA annotation inferred from
phylogenetic analysis (PANTHER:PTN000293176) with evidence from yeast
(SGD:S000001871). In yeast, prefoldin subunits contribute to RNA polymerase III
assembly. This function is consistent with the nuclear roles of prefoldin
subunits but represents a secondary function for PFDN5 in humans.
action: KEEP_AS_NON_CORE
reason: >-
RNA polymerase III assembly is a secondary function for PFDN5, supported by
phylogenetic inference from yeast. Not the core function of PFDN5 in humans.
- term:
id: GO:0016272
label: prefoldin complex
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
GO:0016272 "prefoldin complex" is a core cellular component annotation for
PFDN5. This IBA annotation was inferred from phylogenetic analysis (PANTHER)
with evidence from Drosophila (FB:FBgn0038976), yeast (SGD:S000004559),
Arabidopsis, and human PFDN5. PFDN5 is one of the two alpha subunits (PFDN3
and PFDN5) of the heterohexameric prefoldin complex (PMID:9630229, PMID:30955883).
The complex is registered in ComplexPortal as CPX-6149 and CPX-25767. Liang et al.
2020 (PMID:32699605) confirm: "Eukaryotic prefoldin complex is a heterohexameric
complex like a jellyfish-like structure, consisting of six different subunits
(PFDN1-6): two alpha subunits (PFDN3 and PFDN5) and four beta subunits."
action: ACCEPT
reason: >-
PFDN5 is a core structural alpha subunit of the prefoldin complex. The IBA
annotation is phylogenetically well-supported and consistent with extensive
experimental evidence from cryo-EM structural studies (PMID:30955883) and
reconstitution experiments (PMID:23614719).
supported_by:
- reference_id: PMID:32699605
supporting_text: >-
Eukaryotic prefoldin complex is a heterohexameric complex like a jellyfish-like
structure, consisting of six different subunits (PFDN1–6): two α subunits
(PFDN3 and PFDN5) and four β subunits (PFDN1, PFDN2, PFDN4, and PFDN6) [8]
- reference_id: PMID:30955883
supporting_text: >-
Maintaining proteostasis in eukaryotic protein folding involves cooperation of
distinct chaperone systems.
- term:
id: GO:0005634
label: nucleus
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: >-
GO:0005634 "nucleus" inferred electronically from UniProtKB subcellular location
vocabulary mapping. UniProt records isoform-specific localization: isoform 1
(MM-1alpha) and isoform 3 (MM-1gamma) localize to the nucleus, while isoform 2
(MM-1beta) is cytoplasmic. Liang et al. 2020 (PMID:32699605) confirm: "MM-1alpha
and MM-1gamma are localized in the nucleus." The nuclear localization is consistent
with the moonlighting function of PFDN5/MM-1 as a c-Myc transcriptional corepressor
(PMID:9792694). This IEA annotation is correct and consistent with the TAS annotation
from PMID:9792694.
action: ACCEPT
reason: >-
Nuclear localization of PFDN5 is well-established for the MM-1alpha and MM-1gamma
isoforms. The IEA mapping from UniProt subcellular location is correct and
consistent with the c-Myc corepressor function (PMID:9792694, PMID:32699605).
supported_by:
- reference_id: PMID:32699605
supporting_text: >-
MM-1β and MM-1δ are mainly localized in the cytoplasm, while MM-1α and
MM-1γ are localized in the nucleus, and MM1 isoforms that bind to c-Myc
and TIF1β are located in the nucleus [101].
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: >-
GO:0005737 "cytoplasm" inferred electronically from UniProtKB subcellular location
vocabulary mapping. UniProt records that isoform 2 (MM-1beta) localizes to the
cytoplasm. The prefoldin complex operates primarily in the cytoplasm for its
co-chaperone function (PMID:9630229, PMID:32699605). This IEA annotation is
consistent with the IBA annotation to the same term and is correct.
action: ACCEPT
reason: >-
Cytoplasmic localization is correct for PFDN5 -- both for the canonical prefoldin
complex function and for the MM-1beta isoform specifically. Consistent with the
IBA annotation and experimental evidence.
- term:
id: GO:0006457
label: protein folding
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: >-
GO:0006457 "protein folding" inferred electronically from InterPro domain mapping
(IPR011599, the prefoldin alpha-type domain). This IEA annotation is consistent
with the IDA and NAS annotations to the same term, and with the well-established
role of the prefoldin complex in protein folding (PMID:9630229, PMID:30955883).
action: ACCEPT
reason: >-
The IEA annotation to protein folding via InterPro is correct and consistent
with the higher-confidence IDA and NAS annotations. The prefoldin alpha domain
(IPR011599) is specifically associated with the protein folding function of the
prefoldin complex (PMID:9630229, PMID:30955883).
- term:
id: GO:0016272
label: prefoldin complex
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: >-
GO:0016272 "prefoldin complex" inferred electronically from InterPro domain mapping
(IPR011599, the prefoldin alpha domain). PFDN5 is one of the two alpha subunits
of the heterohexameric prefoldin complex (PMID:9630229, PMID:32699605). This IEA
annotation is consistent with the IBA and IDA annotations to the same term.
action: ACCEPT
reason: >-
PFDN5 is a core structural subunit of the prefoldin complex. The IEA mapping
from the prefoldin alpha domain (IPR011599) to prefoldin complex membership is
appropriate and consistent with experimental evidence (PMID:9630229, PMID:30955883).
- term:
id: GO:0032991
label: protein-containing complex
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: >-
GO:0032991 "protein-containing complex" was inferred electronically by the ARBA
machine learning model (ARBA:ARBA00028902). While technically correct -- PFDN5 is
part of the prefoldin complex, which is indeed a protein-containing complex -- this
annotation is redundant and overly general given the more specific GO:0016272
"prefoldin complex" annotation that is already present from IBA, IEA, and IDA
evidence. The term "protein-containing complex" adds no informational value.
action: MARK_AS_OVER_ANNOTATED
reason: >-
This is an overly general annotation. PFDN5 is part of the prefoldin complex
(GO:0016272), which is a child term of protein-containing complex. The more
specific term is already annotated with IBA, IEA, and IDA evidence. The generic
"protein-containing complex" adds no useful information. Consistent with PFDN1
review decision.
- term:
id: GO:0051082
label: unfolded protein binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: >-
GO:0051082 "unfolded protein binding" is being obsoleted (go-ontology#30962). This
IEA annotation was inferred electronically from InterPro domain mapping (IPR011599,
the prefoldin alpha domain). While prefoldin does indeed bind unfolded proteins, the
term "unfolded protein binding" is a pure binding term that fails to capture the
functional significance of this interaction. Prefoldin acts as a holdase/transfer
chaperone: it captures unfolded substrates (primarily actin and tubulin) and delivers
them to the TRiC/CCT chaperonin for folding (PMID:9630229). The more appropriate
term is GO:0044183 "protein folding chaperone" which captures the functional chaperone
activity rather than just substrate binding. Consistent with PFDN1 review.
action: MODIFY
reason: >-
GO:0051082 is being obsoleted. The term describes only a binding activity and does
not capture the chaperone function of prefoldin. GO:0044183 "protein folding chaperone"
(defined as "Binding to a protein or a protein-containing complex to assist the protein
folding process") is the recommended replacement (PMID:9630229, PMID:30955883).
proposed_replacement_terms:
- id: GO:0044183
label: protein folding chaperone
additional_reference_ids:
- PMID:9630229
- PMID:30955883
supported_by:
- reference_id: PMID:9630229
supporting_text: >-
Prefoldin binds specifically to cytosolic chaperonin (c-cpn) and transfers
target proteins to it.
- reference_id: PMID:30955883
supporting_text: >-
PFD can act after TRiC bound its substrates to enhance the rate and yield
of the folding reaction, suppressing non-productive reaction cycles.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:17728244
review:
summary: >-
GO:0005515 "protein binding" (IPI with UniProtKB:Q9DUN1/vIRF-3) from PMID:17728244,
a study on Kaposi sarcoma-associated herpesvirus vIRF-3 stimulation of c-Myc
transcriptional activity. The UniProt record confirms this interaction (NbExp=8).
This is a viral-host interaction where vIRF-3 interacts with PFDN5/MM-1 to modulate
c-Myc activity. While the interaction may be biologically relevant in the context of
viral infection, "protein binding" is uninformative as an annotation for the host
protein PFDN5.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative. While the PFDN5-vIRF-3 interaction is supported
by multiple experiments and is relevant to viral manipulation of the c-Myc pathway,
the GO term provides no functional insight. The transcriptional corepressor function
is better captured by GO:0003714.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:21516116
review:
summary: >-
GO:0005515 "protein binding" (IPI with UniProtKB:Q13137/CALCOCO2) from PMID:21516116,
a next-generation sequencing study to generate interactome datasets. This is a
high-throughput interaction study. The biological significance of a PFDN5-CALCOCO2
interaction is unclear. "Protein binding" is uninformative.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative. This high-throughput interaction screen detection
does not provide functional insight. The core functions of PFDN5 are already captured
by more specific annotations.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:25036637
review:
summary: >-
GO:0005515 "protein binding" (IPI with UniProtKB:O14775/GNB5, UniProtKB:P62873/GNB1,
UniProtKB:Q9NYS7/WSB2, UniProtKB:Q9UHV9/PFDN2) from PMID:25036637, a quantitative
chaperone interaction network study. The PFDN5-PFDN2 interaction is expected since
both are subunits of the prefoldin complex (UniProt records NbExp=8 for this interaction).
The other interactions are from a large-scale chaperone network study. "Protein binding"
is uninformative.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative. The PFDN5-PFDN2 interaction is already captured
by prefoldin complex membership (GO:0016272). The other interactions detected in the
chaperone network study do not provide functional insight beyond what is captured by
GO:0044183 and GO:0016272.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:25416956
review:
summary: >-
GO:0005515 "protein binding" (IPI with UniProtKB:O76003/GLRX3, UniProtKB:P61289/PSME3,
UniProtKB:Q13137/CALCOCO2, UniProtKB:Q9UKT9/IKZF3) from PMID:25416956, a
proteome-scale map of the human interactome network. These are high-throughput
interactions. The PFDN5-PSME3 interaction (NbExp=6 in UniProt) could reflect a
connection between prefoldin and proteasome regulation, consistent with the known
role of PFDN5/MM-1 in promoting c-Myc proteasomal degradation. However, "protein
binding" remains uninformative.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative. While some interactions (e.g., PSME3) may relate
to the proteasome-mediated c-Myc degradation function of PFDN5, the GO term itself
provides no functional insight. The core functions are captured by more specific terms.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:28514442
review:
summary: >-
GO:0005515 "protein binding" (IPI with UniProtKB:P61758/VBP1, UniProtKB:Q9UHV9/PFDN2)
from Huttlin et al. 2017 (PMID:28514442), the BioPlex human interactome study. The
PFDN5-PFDN2 interaction (NbExp=8) and PFDN5-VBP1 interaction (NbExp=9) reflect
prefoldin complex subunit and prefoldin-like complex interactions. VBP1 (von
Hippel-Lindau binding protein 1) is a prefoldin-like protein. These interactions are
already captured by GO:0016272. "Protein binding" is uninformative.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative. The PFDN5-PFDN2 and PFDN5-VBP1 interactions
reflect co-membership in prefoldin/prefoldin-like complexes, already captured by
GO:0016272. The BioPlex study does not add functional insight beyond complex membership.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:31515488
review:
summary: >-
GO:0005515 "protein binding" (IPI with UniProtKB:Q9UKT9/IKZF3) from PMID:31515488,
a study on extensive disruption of protein interactions by genetic variants. The
PFDN5-IKZF3 interaction (NbExp=7 in UniProt) has been detected in multiple studies.
IKZF3/Aiolos is a transcription factor, and this interaction could relate to PFDN5's
transcriptional regulatory functions. However, "protein binding" is uninformative.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative. While the PFDN5-IKZF3 interaction has been
detected multiple times, the GO term provides no functional insight.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
review:
summary: >-
GO:0005515 "protein binding" (IPI with numerous interactors) from Luck et al. 2020
(PMID:32296183), a reference map of the human binary protein interactome (HuRI).
This study detected a very large number of interactions for PFDN5, including with
other prefoldin subunits (PFDN2, VBP1), transcription factors, and many other proteins.
While the large number of interactions may partly reflect the coiled-coil structure
of PFDN5, "protein binding" is uninformative as a GO annotation.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative. This large-scale binary interactome study detected
many interactions for PFDN5, but the GO term provides no functional insight. The core
molecular functions of PFDN5 are already captured by GO:0044183 (protein folding
chaperone) and GO:0003714 (transcription corepressor activity).
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32814053
review:
summary: >-
GO:0005515 "protein binding" (IPI with UniProtKB:O14901/KLF11, UniProtKB:P42858/HTT,
UniProtKB:Q7Z412/PEX26) from PMID:32814053, an interactome mapping study for
neurodegenerative disease proteins. The PFDN5-HTT (Huntingtin) interaction is
biologically interesting given prefoldin's role in preventing Huntingtin protein
aggregation (PMID:32699605). However, "protein binding" remains uninformative.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative. While the PFDN5-HTT interaction may be relevant
to prefoldin's neuroprotective role, the GO term provides no functional insight.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33961781
review:
summary: >-
GO:0005515 "protein binding" (IPI with UniProtKB:O14775/GNB5, UniProtKB:P61758/VBP1,
UniProtKB:P62873/GNB1, UniProtKB:Q9UHV9/PFDN2) from Huttlin et al. 2021
(PMID:33961781), a dual proteome-scale network study. These are replications of
previously observed interactions. The PFDN5-PFDN2 and PFDN5-VBP1 interactions
reflect prefoldin complex membership. "Protein binding" is uninformative.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative. These are replications of previously observed
interactions that do not add functional insight beyond what is captured by GO:0016272
(prefoldin complex) and GO:0044183 (protein folding chaperone).
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:40205054
review:
summary: >-
GO:0005515 "protein binding" (IPI with UniProtKB:P62873/GNB1, UniProtKB:Q9NYS7/WSB2,
UniProtKB:Q9UHV9/PFDN2) from multimodal cell maps study (PMID:40205054). This is
a further replication of known interactions. "Protein binding" is uninformative.
action: MARK_AS_OVER_ANNOTATED
reason: >-
"Protein binding" is uninformative. These are further replications of known
interactions. The relevant functions are already captured by more specific annotations
(GO:0044183, GO:0016272).
- term:
id: GO:0005829
label: cytosol
evidence_type: IDA
original_reference_id: GO_REF:0000052
review:
summary: >-
GO:0005829 "cytosol" (IDA) from the Human Protein Atlas, based on curation of
immunofluorescence data. The prefoldin complex operates in the cytosol for its
co-chaperone function, binding nascent polypeptides and delivering them to TRiC/CCT
(PMID:9630229). This is consistent with the IBA annotation to "cytoplasm" (GO:0005737)
and provides a more specific localization. The cytosolic localization is expected for
the canonical chaperone function of PFDN5 as part of the prefoldin complex.
action: ACCEPT
reason: >-
Cytosol localization is well-supported by immunofluorescence data and is consistent
with the cytoplasmic co-chaperone function of the prefoldin complex. This provides
a more specific localization than the broader "cytoplasm" annotation.
- term:
id: GO:0006457
label: protein folding
evidence_type: NAS
original_reference_id: PMID:32699605
review:
summary: >-
GO:0006457 "protein folding" (NAS) from ComplexPortal, citing Liang et al. 2020
(PMID:32699605), a comprehensive review of prefoldin complex functions. The review
describes how "the prefoldin complex helps protein fold correctly and prevents
aggregation by providing class II chaperones ... with a linear, unnatural substrate
in the cytoplasm." This NAS annotation is consistent with the IDA annotations to
the same term and is well-supported by the review literature.
action: ACCEPT
reason: >-
Protein folding is the core biological process for PFDN5 as part of the prefoldin
complex. This NAS annotation from ComplexPortal cites a well-sourced review
(PMID:32699605) that accurately describes the protein folding function.
supported_by:
- reference_id: PMID:32699605
supporting_text: >-
The prefoldin complex helps protein fold correctly and prevents aggregation
by providing class II chaperones (Hsp60 molecular chaperones found in
archaebacteria and eukaryotic cytoplasm) with a linear, unnatural substrate
in the cytoplasm [2]
- term:
id: GO:0006457
label: protein folding
evidence_type: NAS
original_reference_id: PMID:34761191
review:
summary: >-
GO:0006457 "protein folding" (NAS) from ComplexPortal, citing Herranz-Montoya et al.
2021 (PMID:34761191), a comprehensive analysis of prefoldins and their implication
in cancer. The review describes prefoldins as "evolutionary conserved co-chaperones"
that "act as co-chaperones escorting misfolded or non-native proteins to group II
chaperonins." This NAS annotation is consistent with the IDA annotations and is
well-supported.
action: ACCEPT
reason: >-
Protein folding is the core biological process for PFDN5. This NAS annotation from
ComplexPortal cites a comprehensive review (PMID:34761191) that accurately describes
the co-chaperone function of prefoldin subunits.
supported_by:
- reference_id: PMID:34761191
supporting_text: >-
PFDNs are prevalently organized into hetero-hexameric complexes. Although
they have been overlooked since their discovery and their functions remain
elusive, several reports indicate they act as co-chaperones escorting
misfolded or non-native proteins to group II chaperonins.
- term:
id: GO:0050821
label: protein stabilization
evidence_type: NAS
original_reference_id: PMID:34761191
review:
summary: >-
GO:0050821 "protein stabilization" (NAS) from ComplexPortal, citing Herranz-Montoya
et al. 2021 (PMID:34761191). The GO definition of protein stabilization is "Any
process involved in maintaining the structure and integrity of a protein and
preventing it from degradation or aggregation." Prefoldin does prevent aggregation
of unfolded substrates by capturing them and delivering them to TRiC/CCT
(PMID:9630229). However, "protein stabilization" typically implies maintaining a
folded protein in its native state, whereas prefoldin acts on unfolded nascent
polypeptides as a holdase and transfer chaperone. The term is not entirely wrong
but mischaracterizes the nature of the chaperone activity. Consistent with PFDN1
review.
action: KEEP_AS_NON_CORE
reason: >-
While prefoldin does prevent protein aggregation (which is part of the GO definition
of protein stabilization), the primary function is not to stabilize already-folded
proteins but rather to capture unfolded substrates and transfer them to TRiC/CCT
for folding. The annotation is not wrong but represents a secondary aspect of
prefoldin function. The core process (protein folding, GO:0006457) is already
well-annotated with IDA and NAS evidence.
supported_by:
- reference_id: PMID:34761191
supporting_text: >-
PFDNs are prevalently organized into hetero-hexameric complexes. Although
they have been overlooked since their discovery and their functions remain
elusive, several reports indicate they act as co-chaperones escorting
misfolded or non-native proteins to group II chaperonins.
- term:
id: GO:0006457
label: protein folding
evidence_type: IDA
original_reference_id: PMID:30955883
review:
summary: >-
GO:0006457 "protein folding" (IDA) from Gestaut et al. 2019 (PMID:30955883), which
used cryo-EM, crosslinking mass spectrometry, and biochemical reconstitution to
characterize the structural and functional interplay between the prefoldin (PFD)
complex and TRiC/CCT chaperonin. The study demonstrates that "PFD can act after
TRiC bound its substrates to enhance the rate and yield of the folding reaction,
suppressing non-productive reaction cycles." This is the highest-quality direct
experimental evidence for the protein folding function of the prefoldin complex.
action: ACCEPT
reason: >-
This IDA annotation is supported by strong direct experimental evidence from Gestaut
et al. 2019 (PMID:30955883), which demonstrated through cryo-EM and biochemical
approaches that the PFD-TRiC supra-chaperone assembly enhances protein folding rates.
Protein folding is the core biological process for PFDN5.
supported_by:
- reference_id: PMID:30955883
supporting_text: >-
PFD can act after TRiC bound its substrates to enhance the rate and yield
of the folding reaction, suppressing non-productive reaction cycles.
- reference_id: PMID:30955883
supporting_text: >-
The supra-chaperone assembly formed by PFD and TRiC is essential to
prevent toxic conformations and ensure effective cellular proteostasis.
- term:
id: GO:0016272
label: prefoldin complex
evidence_type: IDA
original_reference_id: PMID:30955883
review:
summary: >-
GO:0016272 "prefoldin complex" (IDA) from Gestaut et al. 2019 (PMID:30955883). This
study used reconstituted human prefoldin complex (containing all six subunits including
PFDN5) and characterized its structure and function through cryo-EM, crosslinking mass
spectrometry, and biochemical assays. The cryo-EM structures (PDB: 6NR8, 6NR9, 6NRB,
6NRC, 6NRD) include PFDN5 as chain 5. This provides direct structural evidence for
PFDN5 membership in the prefoldin complex.
action: ACCEPT
reason: >-
PFDN5 is a core structural subunit of the prefoldin complex. This IDA annotation is
supported by high-resolution cryo-EM structural data from Gestaut et al. 2019
(PMID:30955883) that directly demonstrates PFDN5 as a component of the human
prefoldin complex.
supported_by:
- reference_id: PMID:30955883
supporting_text: >-
Maintaining proteostasis in eukaryotic protein folding involves cooperation of
distinct chaperone systems. To understand how the essential ring-shaped
chaperonin TRiC/CCT cooperates with the chaperone prefoldin/GIMc (PFD), we
integrate cryoelectron microscopy (cryo-EM), crosslinking-mass-spectrometry
and biochemical and cellular approaches to elucidate the structural and
functional interplay between TRiC/CCT and PFD.
- term:
id: GO:0051082
label: unfolded protein binding
evidence_type: IDA
original_reference_id: PMID:30955883
review:
summary: >-
GO:0051082 "unfolded protein binding" is being obsoleted (go-ontology#30962). This
IDA annotation cites Gestaut et al. 2019 (PMID:30955883), which demonstrated that
prefoldin associates with TRiC through a conserved electrostatic interface and
undergoes conformational cycling between "latched" (open) and "engaged" (closed)
states during substrate transfer. The paper shows that PFD functions not merely as
a passive binder of unfolded substrates but as an active co-chaperone. GO:0044183
"protein folding chaperone" is the appropriate replacement. Consistent with PFDN1
review.
action: MODIFY
reason: >-
GO:0051082 is being obsoleted. Gestaut et al. 2019 (PMID:30955883) demonstrates that
prefoldin functions as a co-chaperone/holdase that cooperates with TRiC/CCT, not
merely as an unfolded protein binder. GO:0044183 "protein folding chaperone" accurately
describes this co-chaperone activity. The GO:0044183 definition ("Binding to a protein
or a protein-containing complex to assist the protein folding process") appropriately
encompasses the holdase/transfer function.
proposed_replacement_terms:
- id: GO:0044183
label: protein folding chaperone
additional_reference_ids:
- PMID:9630229
supported_by:
- reference_id: PMID:30955883
supporting_text: >-
PFD can act after TRiC bound its substrates to enhance the rate and yield
of the folding reaction, suppressing non-productive reaction cycles.
- reference_id: PMID:30955883
supporting_text: >-
PFD alternates between an open "latched" conformation and a closed "engaged"
conformation that aligns the PFD-TRiC substrate binding chambers.
- reference_id: PMID:9630229
supporting_text: >-
Prefoldin binds specifically to cytosolic chaperonin (c-cpn) and transfers
target proteins to it.
- term:
id: GO:0001540
label: amyloid-beta binding
evidence_type: IDA
original_reference_id: PMID:23614719
review:
summary: >-
GO:0001540 "amyloid-beta binding" (IDA) from Sorgjerd et al. 2013 (PMID:23614719).
This study demonstrated that recombinant human prefoldin (hPFD) inhibits
amyloid-beta (Abeta 1-42) fibrillation in vitro and induces formation of soluble
Abeta oligomers with reduced toxicity. The study used thioflavin T measurements
and immunoblotting to show that hPFD directly interacts with Abeta peptides and
modifies their aggregation pathway. While this demonstrates that the prefoldin
complex can bind Abeta, this is not the core function of PFDN5 -- it reflects the
general chaperone/holdase property of prefoldin applied to an amyloidogenic
substrate. The annotation was made on the intact prefoldin complex, not PFDN5
individually.
action: KEEP_AS_NON_CORE
reason: >-
Amyloid-beta binding is a secondary, non-core function that reflects the general
holdase/chaperone activity of the prefoldin complex applied to an amyloidogenic
substrate. The study (PMID:23614719) used the intact hexameric complex rather than
individual PFDN5. While the data are solid, this represents a peripheral function
compared to the core role in actin/tubulin folding via TRiC/CCT delivery. Consistent
with PFDN1 review.
supported_by:
- reference_id: PMID:23614719
supporting_text: >-
we investigated the effect of recombinant human PFD (hPFD) on Abeta(1-42)
aggregation in vitro and found that hPFD inhibited Abeta fibrillation and
induced formation of soluble Abeta oligomers.
- term:
id: GO:0016272
label: prefoldin complex
evidence_type: IDA
original_reference_id: PMID:23614719
review:
summary: >-
GO:0016272 "prefoldin complex" (IDA) from Sorgjerd et al. 2013 (PMID:23614719).
This study expressed and purified recombinant human prefoldin complex (hPFD) to
investigate its effect on amyloid-beta aggregation. The successful reconstitution
and purification of the hexameric complex containing PFDN5 provides direct evidence
for PFDN5 membership in the prefoldin complex. This is consistent with the IDA
annotation from PMID:30955883 and the IBA/IEA annotations.
action: ACCEPT
reason: >-
PFDN5 is a core structural subunit of the prefoldin complex. This IDA annotation
from PMID:23614719 provides independent experimental evidence through reconstitution
of the human prefoldin hexamer, consistent with the structural data from PMID:30955883.
supported_by:
- reference_id: PMID:23614719
supporting_text: >-
Prefoldin (PFD) is a molecular chaperone that prevents aggregation of
misfolded proteins.
- term:
id: GO:1905907
label: negative regulation of amyloid fibril formation
evidence_type: IDA
original_reference_id: PMID:23614719
review:
summary: >-
GO:1905907 "negative regulation of amyloid fibril formation" (IDA) from Sorgjerd
et al. 2013 (PMID:23614719). The study demonstrated that recombinant human prefoldin
"inhibited Abeta fibrillation and induced formation of soluble Abeta oligomers" that
were 30-40% less toxic than Abeta fibrils. Thioflavin T measurements confirmed
reduced fibril formation. While the experimental evidence is sound, this represents
a non-core function of the prefoldin complex -- an extension of its general
holdase/chaperone properties to amyloidogenic substrates. The study was performed on
the intact hexameric complex, not PFDN5 individually.
action: KEEP_AS_NON_CORE
reason: >-
The experimental evidence from PMID:23614719 is solid, but this is a secondary
function reflecting the general anti-aggregation properties of the prefoldin complex
rather than its core role in delivering unfolded actin/tubulin to TRiC/CCT. The
study was performed in vitro on the intact hexameric complex. Consistent with PFDN1
review.
supported_by:
- reference_id: PMID:23614719
supporting_text: >-
we investigated the effect of recombinant human PFD (hPFD) on Abeta(1-42)
aggregation in vitro and found that hPFD inhibited Abeta fibrillation and
induced formation of soluble Abeta oligomers.
- reference_id: PMID:23614719
supporting_text: >-
Our findings show a relation between cytotoxicity of Abeta oligomers and
structure and suggest a possible protective role of PFD in AD.
- term:
id: GO:0045892
label: negative regulation of DNA-templated transcription
evidence_type: IMP
original_reference_id: PMID:18281035
review:
summary: >-
GO:0045892 "negative regulation of DNA-templated transcription" (IMP) from
PMID:18281035, annotated by BHF-UCL. PFDN5/MM-1 is well-established as a
transcriptional corepressor of c-Myc. Mori et al. 1998 (PMID:9792694) originally
identified MM-1 as "a novel c-Myc-associating protein that represses transcriptional
activity of c-Myc." Liang et al. 2020 (PMID:32699605) describe multiple regulatory
mechanisms including inhibition of c-Myc E-box-dependent transcriptional activity
via TIF1beta/HDAC-mSin3 recruitment. This is a well-supported moonlighting function
of PFDN5 that is independent of its prefoldin complex chaperone role.
action: KEEP_AS_NON_CORE
reason: >-
Negative regulation of transcription is a well-supported moonlighting function of
PFDN5/MM-1, independent of its core cytoplasmic co-chaperone role. The c-Myc
corepressor function is mediated by nuclear isoforms (MM-1alpha, MM-1gamma) and
involves recruitment of TIF1beta/HDAC-mSin3 corepressor complex (PMID:9792694,
PMID:32699605). Classified as non-core because the primary function of PFDN5 as a
prefoldin subunit is protein folding chaperone activity.
supported_by:
- reference_id: PMID:32699605
supporting_text: >-
(c)MM-1 inhibits the E-box-dependent transcriptional activity of c-Myc by
recruiting a histone deacetylase (HDAC-mSin3) complex from
TIF1β/KAP1/TRIM28 (a transcriptional co-inhibitor) (Fig
- term:
id: GO:0090090
label: negative regulation of canonical Wnt signaling pathway
evidence_type: IMP
original_reference_id: PMID:18281035
review:
summary: >-
GO:0090090 "negative regulation of canonical Wnt signaling pathway" (IMP) from
PMID:18281035, annotated by BHF-UCL. Liang et al. 2020 (PMID:32699605) describe
this mechanism: MM-1 negatively regulates the expression of wnt4 by binding to
Egr-1, thereby indirectly inhibiting c-Myc expression. This represents one of the
multiple mechanisms by which PFDN5/MM-1 inhibits c-Myc activity. This is part of
the moonlighting transcriptional regulatory function of PFDN5.
action: KEEP_AS_NON_CORE
reason: >-
Negative regulation of Wnt signaling is part of the moonlighting transcriptional
regulatory function of PFDN5/MM-1. It represents one of the multiple mechanisms by
which MM-1 inhibits c-Myc activity (PMID:32699605). This is a secondary function
compared to the core co-chaperone role.
supported_by:
- reference_id: PMID:32699605
supporting_text: >-
MM-1 negatively regulates the expression of wnt4 by binding to Egr-1,
thereby indirectly inhibiting c-Myc expression (Fig
- term:
id: GO:0005737
label: cytoplasm
evidence_type: TAS
original_reference_id: PMID:16130169
review:
summary: >-
GO:0005737 "cytoplasm" (TAS) from PMID:16130169, a proteomics study of human
umbilical vein endothelial cells. This study identified PFDN5 in the proteome of
HUVECs, consistent with its cytoplasmic localization. The cytoplasmic localization
is well-established for the prefoldin complex (PMID:9630229, PMID:32699605) and
is consistent with the IBA and IEA annotations to the same term.
action: ACCEPT
reason: >-
Cytoplasmic localization is well-supported and consistent with the canonical
co-chaperone function of the prefoldin complex. This TAS annotation is consistent
with multiple other annotations to the same term.
- term:
id: GO:0003714
label: transcription corepressor activity
evidence_type: TAS
original_reference_id: PMID:9792694
review:
summary: >-
GO:0003714 "transcription corepressor activity" (TAS) from PMID:9792694, the
original paper by Mori et al. 1998 that identified MM-1 as "a novel c-Myc-associating
protein that represses transcriptional activity of c-Myc." UniProt confirms: "Represses
the transcriptional activity of MYC." Liang et al. 2020 (PMID:32699605) describe
multiple corepressor mechanisms including recruitment of HDAC-mSin3 complex via
TIF1beta/KAP1/TRIM28, proteasomal degradation of c-Myc via Rabring7, and
suppression of Wnt4 via Egr-1. This is a well-characterized moonlighting function
of PFDN5/MM-1 that is distinct from and independent of its prefoldin complex
chaperone role.
action: KEEP_AS_NON_CORE
reason: >-
Transcription corepressor activity is a well-established moonlighting function of
PFDN5/MM-1, distinct from the core cytoplasmic co-chaperone role. It is mediated
specifically by the nuclear isoforms (MM-1alpha, MM-1gamma) and involves binding
to the MBII region of c-Myc's N-terminal domain and recruitment of
TIF1beta/HDAC-mSin3 corepressor complex (PMID:9792694, PMID:32699605). While
this is an important biological function, the primary identity of PFDN5 is as a
prefoldin subunit, so this is classified as non-core.
supported_by:
- reference_id: PMID:32699605
supporting_text: >-
MM-1 is one of the c-Myc NTD-terminated proteins which is bound to the MBII
region of the NTD and can compete with TRRAP for c-Myc [99].
- reference_id: PMID:32699605
supporting_text: >-
MM1, a nuclear c-Myc binding protein, inhibits c-Myc activity in the nucleus
in various ways and is therefore considered a tumor suppressor.
- term:
id: GO:0005634
label: nucleus
evidence_type: TAS
original_reference_id: PMID:9792694
review:
summary: >-
GO:0005634 "nucleus" (TAS) from PMID:9792694, the original paper by Mori et al. 1998
that identified MM-1. The nuclear localization of PFDN5/MM-1 is well-established for
the MM-1alpha and MM-1gamma isoforms, which bind c-Myc and function as transcriptional
corepressors in the nucleus (PMID:32699605). Consistent with the IEA annotation to
the same term from GO_REF:0000044.
action: ACCEPT
reason: >-
Nuclear localization is well-supported for PFDN5 isoforms MM-1alpha and MM-1gamma.
This is consistent with the moonlighting transcriptional corepressor function
(PMID:9792694, PMID:32699605) and the IEA annotation.
supported_by:
- reference_id: PMID:32699605
supporting_text: >-
MM-1β and MM-1δ are mainly localized in the cytoplasm, while MM-1α and
MM-1γ are localized in the nucleus, and MM1 isoforms that bind to c-Myc
and TIF1β are located in the nucleus [101].
- term:
id: GO:0006355
label: regulation of DNA-templated transcription
evidence_type: TAS
original_reference_id: PMID:9792694
review:
summary: >-
GO:0006355 "regulation of DNA-templated transcription" (TAS) from PMID:9792694.
This is a broad parent term that encompasses the more specific GO:0045892 "negative
regulation of DNA-templated transcription" already annotated with IMP evidence from
PMID:18281035. PFDN5/MM-1 is well-established as a transcriptional regulator through
its c-Myc corepressor function. However, this term is redundant with the more specific
GO:0045892 annotation. The annotation should be modified to the more specific child
term or kept as-is since GO:0045892 already exists.
action: KEEP_AS_NON_CORE
reason: >-
Regulation of transcription is well-supported for PFDN5/MM-1 through its c-Myc
corepressor function (PMID:9792694, PMID:32699605). While this term is broader
than the existing GO:0045892 annotation, it is not wrong -- PFDN5 does regulate
transcription. This is a secondary/moonlighting function. The more specific
GO:0045892 from PMID:18281035 provides better resolution.
supported_by:
- reference_id: PMID:32699605
supporting_text: >-
MM1, a nuclear c-Myc binding protein, inhibits c-Myc activity in the nucleus
in various ways and is therefore considered a tumor suppressor.
- term:
id: GO:0044183
label: protein folding chaperone
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
GO:0044183 "protein folding chaperone" is the most appropriate molecular function
term for PFDN5 as a prefoldin subunit. This annotation is proposed as a NEW entry
to match the IBA annotation that exists for PFDN1 (which has this term with IBA
evidence). Prefoldin functions as a holdase/transfer chaperone that captures unfolded
nascent polypeptides and delivers them to TRiC/CCT for folding (PMID:9630229).
Gestaut et al. 2019 (PMID:30955883) demonstrated that the PFD-TRiC supra-chaperone
assembly enhances folding rates. This term is also the recommended replacement for
the obsoleting GO:0051082 "unfolded protein binding." Note: PFDN5 does not currently
have an explicit IBA annotation to GO:0044183 in the GOA data, unlike PFDN1 which
does. The two MODIFY actions for GO:0051082 above recommend this term as replacement.
action: NEW
reason: >-
GO:0044183 "protein folding chaperone" is the core molecular function of PFDN5 as
a prefoldin subunit. PFDN1 already has this annotation with IBA evidence. The
prefoldin complex is a bona fide protein folding chaperone that captures unfolded
substrates and delivers them to TRiC/CCT (PMID:9630229, PMID:30955883). This term
should be added to PFDN5 to replace the obsoleting GO:0051082.
supported_by:
- reference_id: PMID:9630229
supporting_text: >-
We describe the discovery of a heterohexameric chaperone protein, prefoldin,
based on its ability to capture unfolded actin. Prefoldin binds specifically
to cytosolic chaperonin (c-cpn) and transfers target proteins to it.
- reference_id: PMID:30955883
supporting_text: >-
PFD can act after TRiC bound its substrates to enhance the rate and yield
of the folding reaction, suppressing non-productive reaction cycles.
core_functions:
- molecular_function:
id: GO:0044183
label: protein folding chaperone
description: >-
Alpha subunit of the heterohexameric prefoldin co-chaperone complex that
captures unfolded nascent polypeptides -- primarily actin and tubulin -- and
delivers them to the group II chaperonin TRiC/CCT for ATP-dependent folding.
The prefoldin complex acts as a holdase/transfer chaperone that alternates
between open (latched) and closed (engaged) conformations during substrate
handoff to TRiC. The PFD-TRiC supra-chaperone assembly enhances the rate
and yield of the folding reaction and suppresses non-productive reaction
cycles.
supported_by:
- reference_id: PMID:9630229
supporting_text: >-
We describe the discovery of a heterohexameric chaperone protein, prefoldin,
based on its ability to capture unfolded actin. Prefoldin binds specifically
to cytosolic chaperonin (c-cpn) and transfers target proteins to it.
- reference_id: PMID:30955883
supporting_text: >-
PFD can act after TRiC bound its substrates to enhance the rate and yield
of the folding reaction, suppressing non-productive reaction cycles.
directly_involved_in:
- id: GO:0006457
label: protein folding
locations:
- id: GO:0005829
label: cytosol
in_complex:
id: GO:0016272
label: prefoldin complex
- molecular_function:
id: GO:0003714
label: transcription corepressor activity
description: >-
Moonlighting function as c-Myc transcriptional corepressor (MM-1). Nuclear
isoforms (MM-1alpha and MM-1gamma) bind the MBII region of the c-Myc
N-terminal domain and repress c-Myc transcriptional activity through
multiple mechanisms including recruitment of the TIF1beta/HDAC-mSin3
corepressor complex, promotion of c-Myc proteasomal degradation via Rabring7,
and negative regulation of Wnt4 expression via Egr-1 binding. This function
is independent of the cytoplasmic prefoldin co-chaperone role and is mediated
by isoform-specific nuclear localization.
supported_by:
- reference_id: PMID:9792694
supporting_text: >-
MM-1 is a novel c-Myc-associating protein that represses transcriptional
activity of c-Myc.
- reference_id: PMID:32699605
supporting_text: >-
MM-1 inhibits the E-box-dependent transcriptional activity of c-Myc by
recruiting a histone deacetylase (HDAC-mSin3) complex from
TIF1beta/KAP1/TRIM28.
directly_involved_in:
- id: GO:0045892
label: negative regulation of DNA-templated transcription
locations:
- id: GO:0005634
label: nucleus
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied by
UniProt
findings: []
- id: GO_REF:0000052
title: Gene Ontology annotation based on curation of immunofluorescence data
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: PMID:9630229
title: 'Prefoldin, a chaperone that delivers unfolded proteins to cytosolic chaperonin.'
findings:
- statement: >-
Discovered the heterohexameric chaperone protein prefoldin, based on its ability
to capture unfolded actin. Prefoldin binds specifically to cytosolic chaperonin
(c-cpn) and transfers target proteins to it. Deletion of the gene encoding a
prefoldin subunit in S. cerevisiae results in impaired actin and tubulin-based
cytoskeleton functions.
supporting_text: >-
We describe the discovery of a heterohexameric chaperone protein, prefoldin,
based on its ability to capture unfolded actin. Prefoldin binds specifically
to cytosolic chaperonin (c-cpn) and transfers target proteins to it.
- id: PMID:9792694
title: 'MM-1, a novel c-Myc-associating protein that represses transcriptional
activity of c-Myc.'
findings:
- statement: >-
Original identification of MM-1 (PFDN5) as a c-Myc-binding protein that represses
c-Myc transcriptional activity. MM-1 binds the N-terminal domain of c-Myc.
- id: PMID:16130169
title: Proteomics of human umbilical vein endothelial cells applied to etoposide-induced
apoptosis.
findings: []
- id: PMID:17728244
title: Stimulation of c-Myc transcriptional activity by vIRF-3 of Kaposi sarcoma-associated
herpesvirus.
findings: []
- id: PMID:18281035
title: Negative regulation of the Wnt signal by MM-1 through inhibiting expression
of the wnt4 gene.
findings:
- statement: >-
Demonstrates that PFDN5/MM-1 negatively regulates canonical Wnt signaling by
cooperating with Egr-1 to repress Wnt4 transcription, thereby indirectly inhibiting
c-Myc expression.
- id: PMID:21516116
title: Next-generation sequencing to generate interactome datasets.
findings: []
- id: PMID:23614719
title: "Human prefoldin inhibits amyloid-\u03B2 (A\u03B2) fibrillation and contributes\
\ to formation of nontoxic A\u03B2 aggregates."
findings:
- statement: >-
Demonstrated that recombinant human prefoldin (hPFD) inhibits Abeta(1-42)
fibrillation in vitro and induces formation of soluble Abeta oligomers that are
30-40% less toxic. Shows prefoldin complex membership and amyloid-beta binding.
- id: PMID:25036637
title: A quantitative chaperone interaction network reveals the architecture of
cellular protein homeostasis pathways.
findings: []
- id: PMID:25416956
title: A proteome-scale map of the human interactome network.
findings: []
- id: PMID:28514442
title: Architecture of the human interactome defines protein communities and disease
networks.
findings: []
- id: PMID:30955883
title: The Chaperonin TRiC/CCT Associates with Prefoldin through a Conserved Electrostatic
Interface Essential for Cellular Proteostasis.
findings:
- statement: >-
Used cryo-EM, crosslinking mass spectrometry, and biochemical approaches to
characterize the PFD-TRiC supra-chaperone assembly. Demonstrated that PFD enhances
the rate and yield of TRiC-mediated protein folding, and that disrupting the
TRiC-PFD interaction leads to accumulation of amyloid aggregates.
- id: PMID:31515488
title: Extensive disruption of protein interactions by genetic variants across the
allele frequency spectrum in human populations.
findings: []
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings: []
- id: PMID:32699605
title: The functions and mechanisms of prefoldin complex and prefoldin-subunits.
findings:
- statement: >-
Comprehensive review of prefoldin complex functions and individual subunit roles.
Describes PFDN5/MM-1 as the most well-known prefoldin subunit with documented
c-Myc corepressor function through multiple mechanisms: HDAC-mSin3 recruitment,
Rabring7-mediated c-Myc degradation, and Wnt4 repression via Egr-1.
- id: PMID:32814053
title: Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins
and Uncovers Widespread Protein Aggregation in Affected Brains.
findings: []
- id: PMID:33961781
title: Dual proteome-scale networks reveal cell-specific remodeling of the human
interactome.
findings: []
- id: PMID:34761191
title: A comprehensive analysis of prefoldins and their implication in cancer.
findings:
- statement: >-
Describes prefoldins as evolutionary conserved co-chaperones that act as escorts
for misfolded or non-native proteins to group II chaperonins. Comprehensive analysis
of prefoldin genomic alterations across cancer types.
- id: PMID:40205054
title: Multimodal cell maps as a foundation for structural and functional genomics.
findings: []